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SCIENTIFIC OPINION 
Scientific Opinion on applications (EFSA-GMO-UK-2008-57 and EFSA-
GMO-RX-MON15985) for the placing on the market of insect-resistant 
genetically modified cotton MON 15985 for food and feed uses, import and 
processing
1, and for the renewal of authorisation of existing products 
produced from cotton MON 15985
2, both under Regulation (EC) No 
1829/2003 from Monsanto 
EFSA Panel on Genetically Modified Organisms (GMO)
3,4 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Cotton MON 15985 was developed by biolistic transformation of cotton MON 531 to express Cry2Ab2 and 
GUS in addition to the Cry1Ac and NPTII proteins. Cry proteins in MON 15985 confer resistance to major 
lepidopteran  cotton  pests,  whereas  the  GUS  and  NPTII  proteins  were  used  as  markers  during  product 
development. Molecular characterisation of MON 15985 did not give rise to safety issues. The EFSA GMO 
Panel  could  not  conclude  on  the  potential  occurrence  of  unintended  effects  for  agronomic  and  phenotypic 
characteristics owing to data limitations. Compositional data gave no indication of unintended effects for which 
further assessment was needed. The Panel concludes that cotton MON 15985, as described in these applications, 
is  as  safe  and  nutritious  as  its  conventional  counterpart  and  other  non-genetically  modified  varieties,  and 
considers it unlikely that the overall allergenicity of the whole plant is changed. Environmental risk assessment 
was restricted to the exposure through faecal material from animals fed with cotton products of MON 15985 and 
its accidental spillage. Following a weight of evidence approach and considering the poor ability of cotton to 
survive outside cultivated land, despite the agronomic and phenotypic data limitations, the Panel concludes that 
there  is  very  low  likelihood  of  any  adverse  environmental  impacts.  The  aadA  and  oriV  sequences  in 
MON 15985  may  facilitate  the  stabilisation  of  nptII  through  double  homologous  recombination.  However, 
considering  the  limited  presence  of  intact  DNA  from  MON 15985  in  feed  and  the  limited  occurrence  of 
horizontal transfer of DNA from plant material to bacteria, the Panel concludes that it is highly unlikely that 
nptII from MON 15985 will be transferred to bacteria. 
© European Food Safety Authority, 2014 
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SUMMARY 
Following requests from the Competent Authority of the United Kingdom and from the European 
Commission  (EC),  the  Panel  on  Genetically  Modified  Organisms  of  the  European  Food  Safety 
Authority (EFSA GMO Panel) was asked to deliver a scientific opinion on applications EFSA-GMO-
UK-2008-57  and  EFSA-GMO-RX-MON15985  respectively,  both  submitted  by  Monsanto  under 
Regulation (EC) No 1829/2003
5. While application EFSA-GMO-UK-2008-57 is for the placing on the 
market of cotton MON 15985 for food and feed uses, EFSA-GMO-RX-MON15985 is for the renewal 
of authorisation for continued marketing of: 
  food additives produced from cotton MON 15985, authorised under Directive 89/107/EEC
6; 
  feed produced from cotton MON 15985 (feed materials and feed additives), authorised under 
Directive 70/524/EEC
7. 
After the date of entry into force of Regulation (EC)  No 1829/2003, the products mentioned above 
were notified to the EC  in accordance with  Articles  8(1)(b) or 20(1)(b) of this Regulation and 
subsequently included in the European Union (EU) Register of authorised GMOs
8. 
Since both EFSA-GMO-UK-2008-57  and EFSA-GMO-RX-MON15985  cover cotton MON 15985, 
the EFSA GMO Panel provides a single scientific opinion, valid for both applications. 
The EFSA GMO Panel evaluated cotton  MON 15985 with reference to the  scope and appropriate 
principles described in its guidance documents for the risk assessment of  genetically modified (GM) 
plants and derived food and feed (EFSA,  2006a; EFSA GMO Panel ,  2011a),  environmental risk 
assessment (ERA) (EFSA GMO Panel, 2010a) and for renewal of authorisations of existing GMO 
products  lawfully  placed  on  the  market  (EFSA,  2006b).  The  scientific  evaluation  of  the  risk 
assessment included molecular characterisation of the inserted DNA and analysis of the expression of 
the corresponding proteins. An evaluation of the comparative analyses of compositional, agronomic 
and phenotypic characteristics was undertaken, and the safety of the newly expressed proteins and the 
whole  food/feed  was  evaluated  with  respect  to  potential  toxicity,  all ergenicity  and  nutritional 
wholesomeness.  An  evaluation  of  environmental  impacts  and  the  post -market  environmental 
monitoring (PMEM) plan was also undertaken. 
The scope of applications EFSA -GMO-UK-2008-57  and EFSA-GMO-RX-MON15985 covers the 
MON 15985  event  in cotton species  Gossypium  hirsutum  L.  and  G.  barbadense  L.  The  genus 
Gossypium consists of more than 50 species, two of which are the most commonly cultivated species 
(G. hirsutum and G. barbadense). The composition of cottonseed from G. barbadense does not differ 
from that of seed from G. hirsutum to the extent that a food and feed risk assessment of one species 
would not be applicable also to the other. 
Cotton MON 15985 was obtained by the transformation of GM cotton MON 531 (unique identifier 
MON-ØØ531-6) with a DNA fragment carrying two expression cassettes: cry2Ab2 and uidA. While 
expression of the Cry2Ab2 protein confers resistance to the major lepidopteran cotton pests including 
the cotton bollworm, tobacco budworm and the pink bollworm, the GUS E377K protein, produced by 
the uidA gene, was used as a histochemical marker during product development. 
Cotton  MON 531  has  been  developed  to  produce  a  synthetic  variant  of  the  Cry1Ac  protein.  In 
addition, cotton MON 531 contains a kanamycin resistance gene (nptII) under plant expression signals 
and the streptomycin/spectinomycin resistance gene aadA under the control of its bacterial promoter. 
                                                       
5  Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically 
modified food and feed. OJ L 268, p. 1–23. 
6  Council Directive 89/107/EEC of 21 December 1988 on the approximation of the laws of the Member Sta tes concerning 
food additives authorized for use in foodstuffs intended for human consumption. OJ L 40, p. 27–33. 
7  Council Directive 70/524/EEC of 23 November 1970 concerning additives in feeding-stuffs. OJ L 270, p. 1–17. 
8  http://ec.europa.eu/food/dyna/gm_register/index_en.cfm Scientific Opinion on genetically modified cotton MON 15985  
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Cotton  MON 531  has  been  assessed  previously  (EFSA  GMO  Panel,  2011b)  on  the  basis  of 
experimental data. No concerns were identified for human and animal health and the environment. The 
molecular characterisation data provided for cotton MON 15985 did not give rise safety issues. 
The  EFSA  GMO  Panel  could  not  complete  the  assessment  of  the  agronomic  and  phenotypic 
characteristics of cotton MON 15985 on the basis of the data provided (a single season and fewer than 
eight sites (EFSA, 2006a; EFSA GMO Panel 2011a)). Therefore, the EFSA GMO Panel could not 
conclude on the potential occurrence of unintended effects based on the outcome of the agronomic and 
phenotypic analysis. The EFSA GMO Panel concludes that the compositional data give no indication 
that the genetic modification induces unintended effects for which further assessment is needed. The 
EFSA GMO Panel concludes that cotton MON 15985 is as safe and nutritious as its conventional 
counterpart and that it is unlikely that the overall allergenicity of the whole plant is changed. 
Applications  EFSA-GMO-UK-2008-57  and  EFSA-GMO-RX-MON15985  cover  the  import, 
processing, and food and feed uses of cotton MON 15985. Therefore, there is no requirement for 
scientific  information  on  possible  environmental  effects  associated  with  the  cultivation  of  cotton 
MON 15985. In accordance with its guidance document on the ERA of GM plants (EFSA, 2010a), the 
EFSA  GMO  Panel  follows  a  weight  of  evidence  approach  in  collating  and  assessing  appropriate 
information from various data sources (e.g. molecular and compositional data, available agronomic 
and phenotypic data from field trials performed by the applicant, literature) in order to assess the 
likelihood  of  unintended  effects  on  the  environment.  Notwithstanding  the  incompleteness  of  the 
agronomic and phenotypic dataset, the EFSA GMO Panel followed a weight of evidence approach 
and,  considering  the  scope  of  this  application  and  the  poor  ability  of  cotton  to  survive  outside 
cultivated fields, concluded that there is very low likelihood of any adverse environmental impacts due 
to the accidental release into the environment of viable seeds from cotton MON 15985. The aadA and 
oriV sequences in MON 15985 may facilitate the stabilisation of nptII through double homologous 
recombination in plasmid sequences in the environment. However, considering the limited presence of 
intact DNA from MON 15985 in feed and processed feed owing to the low percentage of cotton plant 
material allowed in feed products, and the limited occurrence of horizontal transfer of DNA from plant 
material to bacteria, the EFSA GMO Panel concludes that it is highly unlikely that cotton MON 15985 
will contribute to the environmental prevalence of nptII genes. The scope of the PMEM plan provided 
by the applicant is in line with the intended uses of cotton MON 15985. Furthermore, the EFSA GMO 
Panel agrees with the reporting intervals proposed by the applicant in the general surveillance plan. 
In delivering its scientific opinion, the EFSA GMO Panel considered applications EFSA-GMO-UK-
2008-57  and  EFSA-GMO-RX-MON15985,  additional  information  submitted  by  the  applicant  on 
request of the Panel, the scientific comments submitted by Member States and relevant scientific 
publications. In accordance with its guidance document for renewal of authorisations of existing GMO 
products (EFSA, 2006b), the EFSA GMO Panel took into account the new information, experience 
and data on cotton MON 15985 that became available during the authorisation period. 
The EFSA GMO Panel considers that the dossiers presented by the applicant had deficiency in the 
data set relative to agronomic and phenotypic trials, however the EFSA GMO Panel concludes that 
cotton  MON 15985,  as  described  in  applications  EFSA-GMO-UK-2008-57  and  EFSA-GMO-RX-
MON15985, is as safe as its conventional counterpart and non-GM cotton commercial varieties, and is 
unlikely to have adverse effects on human and animal health and the environment in the context of the 
scope of these applications. Scientific Opinion on genetically modified cotton MON 15985  
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BACKGROUND 
On 22 May 2008, the European Food Safety Authority (EFSA) received from the United Kingdom 
Competent  Authority  an  application  (EFSA-GMO-UK-2008-57)  for  authorisation  of  genetically 
modified (GM) cotton MON 15985 (Unique Identifier MON-15985-7) submitted by Monsanto within 
the  framework  of  Regulation  (EC)  No  1829/2003  on  GM  food  and  feed.  After  receiving  the 
application  EFSA-GMO-UK-2008-57,  and  in  accordance  with  Articles  5(2)(b)  and  17(2)b  of 
Regulation (EC) No 1829/2003, EFSA informed the Member States and the European Commission 
(EC)  and  made  the  summary  of  the  application  publicly  available  on  the  EFSA  website
9. EFSA 
initiated a formal review of the application to check compliance with the requirements laid down in 
Articles 5(3) and 17(3) of Regulation (EC) No 1829/2003. On  20 August 2008, EFSA declared the 
application as valid in accordance with Articles 6(1) and 18(1) of Regulation (EC) No 1829/2003. 
On  29  June  2007,  EFSA  received  from  the  EC  an  application  (EFSA -GMO-RX-MON15985) 
submitted under Regulation (EC) No 1829/2003 for renewal of the authorisation of food additives and 
feed produced from cotton MON 15985 (feed materials and feed additives). 
The scope of the renewal application, as described in the  EU Register of authorised GMOs
10, covers 
the continued marketing of: 
  food additives produced from cotton MON 15985, authorised under Directive 89/107/EEC; 
  feed produced from cotton MON 15985 (feed materials and feed additives), authorised under 
Directive 70/524/EEC. 
After receiving the renewal application EFSA-GMO-RX-MON15985 and in accordance with Articles 
5(2)(b) and 17(2)b of Regulation (EC) No 1829/2003, EFSA informed Member States as well as the 
EC  and  made  the  summary  of  this  application  publicly  available  on  the  EFSA  website
11. EFSA 
initiated a formal review of the renewal application to check compliance with the requirements laid 
down in Articles  5(3) and 17(3) of Regulation (EC) No  1829/2003. On 18  March  2008, EFSA 
declared the application as valid in accordance with Articles  6(1) and 18(1) of Regulation (EC) No 
1829/2003. 
EFSA  made  the  valid  applications  EFSA -GMO-UK-2008-57  and  EFSA-GMO-RX-MON15985 
available to Member States and the EC, and consulted nominated risk assessment bodies of Member 
States, including national Competent Authorities within the meaning of Directive 2001/18/EC
12, to 
request their scientific opinion. The Member State bodies had 3 months after the date of receipt of the 
valid application (until 20 November 2008 and 18 June 2008, respectively) within which to make their 
opinion known. 
The scope of applications EFSA -GMO-UK-2008-57  and EFSA-GMO-RX-MON15985  covers the 
MON 15985 event in cotton species Gossypium hirsutum L. and G. barbadense L
13. 
The EFSA GMO Panel carried out an evaluation of the risk assessment of the applications on cotton 
MON 15985 in accordance with Articles 6(6) and 18(6) of Regulation (EC) No 1829/2003. The Panel 
took  into  account  the  approp riate  principles  described  in  its  guidance  documents  for  the  risk 
assessment of GM plants and derived food and feed (EFSA,  2006a;  EFSA GMO Panel  2011a), 
environmental risk assessment ( EFSA GMO Panel,  2010a)  and for renewal of authorisations of 
existing GMO products lawfully placed on the market (EFSA,  2006b). Furthermore, the scientific 
                                                       
9  http://registerofquestions.efsa.europa.eu/roqFrontend/questionLoader?question=EFSA-Q-2008-385 
10 http://ec.europa.eu/food/dyna/gm_register/gm_register_auth.cfm?pr_id=6 
11 http://registerofquestions.efsa.europa.eu/roqFrontend/questionLoader?question=EFSA-Q-2007-145 
12 Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the 
environment of genetically modified organisms and repealing Council Directive 90/220/EEC. OJ L 106, p. 1–39. 
13 Clarification from the applicant: 15/09/2010. Scientific Opinion on genetically modified cotton MON 15985  
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comments  of  Member  States,  the  additional  information  provided  by  the  applicant  and  relevant 
scientific publications were also taken into consideration. 
For  EFSA-GMO-UK-2008-57,  the  EFSA  GMO  Panel  requested  additional  information  from  the 
applicant on 20 August 2008, 24 November 2008, 7 April 2009, 28 May 2009, 19 September 2009, 15 
March 2010, 4 October 2010, 31 January 2011, 5 December 2011, 6 July 2012, 9 January 2012, 3 June 
2013, and on 23 August 2013. The applicant provided additional information on 15 September 2010, 2 
December 2010, 11 April 2011, 14 September 2012, 5 November 2012, 12 March 2013, 5 November 
2013, and on 11 November 2013. 
For EFSA-GMO-RX-MON15985, the EFSA GMO Panel requested additional information from the 
applicant on 26 May 2008, 24 November 2008, 7 April 2009, 26 May 2009, 18 September 2009, 12 
March 2010, 4 October 2010, 31 January 2011, 5 December 2011, 6 July 2012, 9 January 2013, 3 June 
2013, and on 23 August 2013. The applicant provided additional information on 28 October 2008, 9 
March 2009, 19 May 2009, 18 January 2010, 30 June 2010, 15 September 2010, 29 September 2010, 2 
December 2010, 11 April 2011, 14 September 2012, 5 November 2012, 12 March 2013, 5 November 
2013, and on 11 November 2013. 
In giving its scientific opinion on cotton MON 15985 to the EC, the Member States and the applicant, 
and  in  accordance  with  Articles  6(1)  and  18(1)  of  Regulation  (EC)  No  1829/2003,  EFSA  has 
endeavoured to respect a time limit of 6 months from the acknowledgement of the valid application. 
As additional information was requested by the EFSA GMO Panel, the time limit of 6 months was 
extended  accordingly,  in  line  with  Articles  6(1),  6(2),  18(1),  and  18(2)  of  Regulation  (EC)  No 
1829/2003. 
According  to  Regulation  (EC)  No  1829/2003,  this  scientific  opinion  is  to  be  seen  as  the  report 
requested under Articles 6(6) and 18(6) of that Regulation and thus will be part of the respective 
overall opinions in accordance with Articles 6(5) and 18(5). 
TERMS OF REFERENCE 
The EFSA GMO Panel was requested to carry out a scientific assessment of cotton  MON 15985 
(Unique  Identifier:  MON-15985-7)  in  the  context  of  applications  EFSA-GMO-UK-2008-57  and 
EFSA-GMO-RX-MON15985. While application EFSA-GMO-UK-2008-57 is for the placing on the 
market cotton MON 15985 for food and feed uses, the scope of EFSA-GMO-RX-MON15985 covers 
the renewal of authorisation of (1) food additives produced from cotton MON 15985, authorised under 
Directive 89/107/EEC; (2) feed produced from cotton MON 15985 (feed materials and feed additives), 
authorised under Directive 70/524/EEC notified to the EC according to Articles 8(1)(b) or 20(1)(b) of 
this Regulation (EC) No 1829/2003, respectively. 
Where  applicable,  any  conditions  or  restrictions  which  should  be  imposed  on  the  placing  on  the 
market  and/or  specific  conditions  or  restrictions  for  use  and  handling,  including  post-market 
monitoring requirements based on the outcome of the risk assessment and, in the case of GMOs or 
food/feed  containing  or  consisting  of  GMOs,  conditions  for  the  protection  of  particular 
ecosystems/environments and/or geographical areas should be indicated in accordance with Articles 
6(5)(e) and 18(5)e of Regulation (EC) No 1829/2003. 
The EFSA GMO Panel was not requested to give a scientific opinion on information required under 
Annex II of the Cartagena Protocol. Furthermore, the EFSA GMO Panel did not consider proposals 
for  labelling  and  methods  of  detection  (including  sampling  and  the  identification  of  the  specific 
transformation event in the food/feed and/or food/feed produced from it), which are matters related to 
risk management. 
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ASSESSMENT 
1.  Introduction 
Cotton MON 15985 (Unique Identifier MON-15985-7) is assessed with reference to its intended uses, 
taking account of the appropriate principles described in the guidance documents of the EFSA Panel 
on  Genetically  Modified  Organisms  (EFSA  GMO  Panel)  for  the  risk  assessment  of  genetically 
modified  (GM)  plants  and  derived  food  and  feed  (EFSA,  2006a;  EFSA  GMO  Panel,  2011a), 
environmental  risk  assessment  (ERA)  (EFSA  GMO  Panel,  2010a)  and  for  the  renewal  of 
authorisations of existing GMO products lawfully placed on the market (EFSA,  2006b). The risk 
assessment presented here is based on the information provided in the applications relating to cotton 
MON 15985, additional information from the applicant, scientific comments raised by Member States 
and relevant scientific publications. 
The scope of applications EFSA-GMO-UK-2008-57 and EFSA-GMO-RX-MON15985 is for food and 
feed  uses,  for  food  additives  and  feed  produced  from  cotton  MON 15985  and  for  import  and 
processing; it does not include cultivation in the EU. Thus, cotton MON 15985 will be imported into 
the EU for the above-listed uses in the same way as any commercial cotton variety. 
To obtain cotton MON 15985, Gossypium hirsutum L. was genetically transformed; however, the 
scope  of  applications  EFSA-GMO-UK-2008-57  and  EFSA-GMO-RX-MON15985  covers  the 
MON 15985 event in cotton species G. hirsutum L. and G. barbadense L
14. Since there are no known 
genetic barriers to interspecies hybridisation between the tetraploid Gossypium species (Percival et al., 
1999), the MON 15985 event could possibly be introgressed in G. barbadense through conventional 
breeding.  At  the  request  of  the  EFSA  GMO  Panel,  the  applicant  provided  information  that  the 
composition of cottonseed from G. barbadense does not differ from that of G. hirsutum regarding 
nutrients, anti-nutrients and toxicants, to such an extent that a food and feed risk assessment of one of 
these species would not also be applicable for the other species
15. Therefore, the food and feed risk 
assessment of the  MON 15985  event in cotton considered in this opinion is applicable to both 
G. barbadense and G. hirsutum. 
Cotton MON 15985 was obtained by the transformation of GM cotton MON 531 (Unique Identifier 
MON-ØØ531-6)  with  a  DNA  fragment  carrying  two  expression  cassettes:  cry2Ab2  and  uidA. 
Expression of the Cry2Ab2 protein confers resistance to major lepidopteran cotton pests including the 
cotton bollworm, tobacco budworm and the pink bollworm, while the GUS E377K protein, produced 
by the uidA gene, was used as a histochemical marker during product development. 
Cotton  MON 531  has  been  developed  to  produce  a  synthetic  variant  of  the  Cry1Ac  protein.  In 
addition, cotton MON 531 contains a kanamycin resistance gene (nptII) under plant expression signals 
and the streptomycin/spectinomycin resistance gene aadA under the control of its bacterial promoter. 
Cotton  MON 531  has  been  assessed  previously  (EFSA  GMO  Panel,  2011b)  on  the  basis  of 
experimental data. No concerns for human and animal health and the environment were identified. 
The genetic modifications in cotton MON 15985 are intended to improve agronomic performance only 
and are not intended to influence the nutritional properties, processing characteristics or overall use of 
cotton as a crop. 
Cotton MON 15985 was first commercially grown in 2003 in the USA and in Australia, and later as 
the combined-trait product MON 15985 × MON 1445. In 2006, cottons containing event MON 15985 
amounted to 7 % and 97 % of total cotton production in the USA and Australia, respectively. Most of 
this was cotton MON 15985 × MON 1445
16. 
                                                       
14 Clarification from the applicant: 15/09/2010. 
15 Additional information: 11/04/2011. 
16 EFSA applications EFSA-GMO-UK-2008-58 and EFSA-GMO-RX-MON15985xMON1445. Scientific Opinion on genetically modified cotton MON 15985  
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Based  on  import  data  of  cottonseed  meal  from  cotton  MON 15985-producing  countries  into  the 
countries of the European Union (EU)
17, the applicant has estimated that around 0.035 % of cottonseed 
meal used in the EU might be derived from cotton  MON 15985 and its combined-trait products. It 
should be noted, however, that the calculation yielding these figures is based on several assumptions 
and may vary between Member States. 
2.  Issues raised by the Member States 
The comments raised by Member States are addressed in Annex G of the relevant EFSA overall 
opinion and were taken into consideration during the evaluation of the risk assessment
18,19. 
3.  Molecular characterisation 
3.1.  Evaluation of relevant scientific data 
Cotton MON 15985 was obtained by the transformation of GM cotton MON 531, previously assessed 
by EFSA (EFSA GMO Panel, 2011b). Therefore, molecular characterisation of cotton MON 15985 
includes both a summary of event MON 531 and the description of the second genetic modification, 
leading to cotton MON 15985. 
3.1.1.  Summary  of  the  previous  evaluation  of  event  MON 531,  including  newly  provided 
information 
Cotton MON 531 contains two insertions, one functional and the other non-functional. The functional 
insert contains 7 916 bp of the transforming PV-GHBK04 plasmid, extending from the right transfer-
DNA  (T-DNA)  border  (RB)  through  the  cry1Ac  expression  cassette,  the  aadA  gene,  the  nptII 
expression cassette  up  to the  oriV  genetic  element.  In  addition,  another  3′  portion of  the  cry1Ac 
expression cassette up to the RB is linked to the complete cry1Ac expression cassette in opposite 
orientation, arranged as an inverted repeat. The non-functional insert of 242 bp consists of the RB and 
a  portion  of  the  7S  3′  transcriptional  termination  sequence.  Molecular  characterisation  of  cotton 
MON 531 has been described and assessed previously by the EFSA GMO Panel (EFSA GMO Panel, 
2011b). Cotton MON 531 includes two bacterial antibiotic resistance genes and other sequences of 
bacterial origin, which may allow double homologous recombination to plasmid sequences present in 
the environment. 
Updated  bioinformatic  analyses
20 of the insertion sites indicated t hat the functional insert did not 
disrupt known endogenous genes. Flanking sequences of the non -functional insert suggest that the 
insertion occurred in a 26S ribosomal RNA  (rRNA) gene. Since rRNA genes are present in several 
copies in the genome (Ide et al., 2010), disruption of a single copy is unlikely to have an effect on the 
characteristics of the plant. 
In order to assess whether the open reading frames (ORFs) present within the inserts and spanning the 
junction sites  give rise to any safety issues, their putative translation products were compared for 
similarities to known allergens and toxins by using suitable algorithms and appropriate databases
21. 
None of the ORF -derived amino acid sequences identified at the junctions and in the inserted 
sequences showed significant similarities with known toxins. Allergen search identified a 10 -amino 
acid-long stretch at the   5′  end  of  the  7S  transcriptional  terminators,  showing  identity  to  beta-
conglycinin-alpha  storage  protein  (alternative  name  of  the  7S  seed  storage  protein,  of  which  the 
coding gene is the source of the 7S terminator). These 10 amino acid residues correspond to the 
carboxyl-terminus of the 7S seed storage protein. Since 36 nt upstream of the corresponding DNA 
                                                       
17 FAO  Statistics data of  import  of  cottonseed  meal  in  countries of  the  European  Union  over  the  years 2003  to  2005. 
http://faostat.fao.org 
18 http://registerofquestions.efsa.europa.eu/roqFrontend/questionLoader?question=EFSA-Q-2008-385 
19 http://registerofquestions.efsa.europa.eu/roqFrontend/questionLoader?question=EFSA-Q-2007-145 
20 Additional information: 05/11/2013. 
21 Additional information: 05/11/2013. Scientific Opinion on genetically modified cotton MON 15985  
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fragment there is a stop codon in the same reading frame, and no start codon is present in between, the 
translation of this sequence is highly unlikely. 
Review of the scientific literature covering the period since the publication of the last EFSA scientific 
opinion on cotton MON 531 (EFSA GMO Panel, 2011b) identified no molecular characterisation-
related hazards. 
Consequently, the EFSA GMO Panel considers that its previous conclusions on the safety of cotton 
MON 531 event remain valid. 
3.1.2.  Transformation process and vector constructs 
Cotton MON 15985 was developed by particle bombardment of cotton MON 531 meristems
22. The 
DNA used in the transformation was a 6  091 bp linear KpnI fragment derived from plasmid PV-
GHBK11. The DNA fragment contained two adjacent expression cassettes. One expression cassette 
contained the Escherichia coli uidA coding sequence under the control of the e35S promoter and the 3′ 
termination signals of the Agrobacterium tumefaciens nopaline synthase (nos) gene. The uidA gene 
encodes β-D-glucuronidase, which catalyses the hydrolysis of a range of β-D-glucuronides, including 
the chromogenic artificial substrate p-nitrophenyl-β-D-glucuronide. It was used as a histochemical 
marker (reporter) for transgenic tissues. No selectable markers were used. The second expression 
cassette contained the e35S promoter, the 5′ untranslated leader sequence of the Petunia heat shock 
protein 70, the N-terminal chloroplast transit peptide from the Arabidopsis thaliana epsps gene, the 
coding sequence of a synthetic cry2Ab2 gene and the 3′ termination signals of the A. tumefaciens nos 
gene. The resulting Cry2Ab2 protein differs from that of the native Cry2Ab protein from Bacillus 
thuringiensis by five amino acids at the N-terminus, which corresponds to the predicted region of the 
chloroplast transit peptide remaining after processing and a residue introduced for cloning purposes
23. 
This  second  genetic  modification  is  referred  to  as  MON 15947.  Genetically  fixed  germplasm, 
homozygous for both  cry1Ac  and  cry2Ab2  (from  MON 531  and  MON 15947,  respectively)  was 
produced by traditional breeding processes including stabilisation, backcrossing and selfing, and is 
referred to as MON 15985
24. 
3.1.3.  Transgene constructs in the GM plant 
Molecular characterisation of cotton MON 15985 was performed by Southern analysis, polymerase 
chain reaction (PCR) and DNA sequence analysis, in order to determine insert copy number, size and 
organisation of the inserted sequences and to confirm the absence of plasmid backbone sequences
25. 
The approach used was acceptable in terms of both coverage and sensitivity. 
Southern analysis of cotton control DNA, cotton  MON 531 and cotton MON 15985 DNA digested 
separately with two different restriction enzymes, one cutting inside the expected insert sequence and 
one not cutting, using th e PV-GHBK11 plasmid as a probe indicated the integration of a single 
MON 15947 insert into the cotton genome. This was supported by PCR analysis of five overlapping 
regions that span the entire length of the insert and by sequence analysis. The integrity o f the 
functional insert of event  MON 531 in the R3 generation of MON 15985 has been demonstrated by 
Southern analysis spanning the flanking regions
26. Therefore, there is no indication of rearrangements 
resulting from an interaction between the events.  The absence of additional DNA sequences derived 
from the vector PV-GHBK11 in MON 15985 plants has been confirmed by Southern analysis using 
probes that cover the entire sequence of the vector backbone. 
                                                       
22 Technical dossier, Section C1. 
23 Technical dossier, Sections C2 and C3. 
24 Technical dossier, Section A6. 
25 Technical dossier, Section D2. 
26 Additional information: 19/05/2009. Scientific Opinion on genetically modified cotton MON 15985  
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The nucleotide sequence of the MON 15947 insert in cotton MON 15985 has been determined in its 
entirety. The insert contains 5719 bp derived from the KpnI fragment of PV-GHBK11 plasmid used 
for transformation. At the 5′ end 307 bp and at the 3′ end 66 bp of the KpnI fragment are missing from 
the transformed plant. The deduced amino acid sequence of the coding sequence of cry2Ab2 is as 
expected from the PV-GHBK11 sequence, but the inserted β-D-glucuronidase sequence differs by one 
amino acid (E377K). Flanking sequences extending 1599 bp from the 5′ end and 636 bp from the 3′ 
end of the MON 15947 insert were also determined
27. 
Updated bioinformatic analyses
28 of the insertion site indicated that the  MON 15947 insert did not 
disrupt known endogenous genes. During the transformation process, 1 847 bp of additional DNA was 
co-inserted with the intended sequences. The 5′ flank of the MON 15947 insert consists of 1 524 bp of 
additional DNA, of which 389 bp shows similarity to chloroplast DNA and 124 bp to A. thaliana 
putative  dynamin-like  protein  cDNA  and  1 011 bp  represents  unidentified  DNA.  The  3′  flanking 
sequence  consist  of  323 bp  unidentified  DNA.  The  chloroplast  DNA  inserted  at  the  5′  flank  is 
homologous to a part of NADH dehydrogenase subunit B that does not give rise to any safety issues. 
In order to assess whether the ORFs present within the inserts (including the DNA co-inserted with the 
MON 15947  insert)  and  spanning  the  junction  sites  give  rise  to  any  safety  issues,  their  putative 
translation products were compared for similarities to known allergens and toxins by using suitable 
algorithms and appropriate databases
29. None of the ORF-derived amino acid sequences identified at 
the junctions and in the inserted sequences showed significant similarities with kno wn toxins or 
allergens. These bioinformatic analyses support the conclusion that, even in the unlikely event that any 
of the new ORFs at the junctions were translated, they would not give rise to a safety issue. 
3.1.4.  Information on the expression of the insert 
Cotton MON 15985 contains two inserts: (1) the MON 531 insert with the cry1Ac, nptII and aadA 
genes and (2) the MON 15947 insert with the cry2Ab2 and uidA genes. The expression levels of the 
Cry1Ac,  NPTII,  Cry2Ab2  and  β-D-glucuronidase  proteins  were  measured  by  enzyme-linked 
immunosorbent assay (ELISA) in different samples of cotton MON 15985 cultivated in two field trials 
in the USA in 1998 (eight locations) and in 2001 (five locations). All locations represented major 
cotton-growing regions of the USA
30. The mean values and ranges of the protein levels in the seeds 
are summarised in Table  1. The expression levels of the Cry1Ac and NPTII proteins were similar 
between  MON 15985  and  MON 531  when  compared  within  the  same  year  and  location.  The 
expression levels of Cry2Ab2 and β-D-glucuronidase were similar in MON 15985 and MON 15947 in 
the 2001 trial. As expected, AAD protein was not detected in any of the samples analysed since the 
aadA gene is under the control of a prokaryotic promoter. Substantial changes in protein expression 
levels are expected if interactions at the DNA and RNA level, such as gene silencing, occur. Only 
small changes in protein expression levels were observed (see Table 1 for an example in seed). Taking 
this into account, as well as the inherent variability of plants, the observed small changes do not 
indicate the occurrence of interactions between the two transformation events in cotton MON 15985. 
   
                                                       
27 Technical dossier, Section D2(b). 
28 Additional information: 05/11/2013. 
29 Additional information: 05/11/2013. 
30 Technical dossier, Section D3; additional information: 14/09/2012. Scientific Opinion on genetically modified cotton MON 15985  
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Table 1:   Protein expression levels in cotton MON 15985, MON 531 and MON 15947 seed (μg/g 
fresh weight) 
Year  Event  Cry1Ac  NPTII  Cry2Ab2  β-D-Glucuronidase 
1998  MON 15985  3.35 (0.63) 
2.21–4.84 
10.8 (1.2) 
8.88–13.2 
43.2 (5.7) 
31.8–50.7 
58.8 (13.0) 
37.2–82.3 
MON 531  3.22 (0.77) 
1.50–4.46 
9.92 (2.19) 
3.81–12.6 
< LOD  < LOD 
2001  MON 15985  1.6 (0.23) 
1.3–1.9 
5.5 (0.59) 
4.8–6.2 
44 (10) 
34–60 
46 (13) 
27–59 
MON 531  1.7 (0.079) 
1.6–1.8 
5.2 (0.5) 
4.7–6.0 
< LOD  < LOD 
MON 15947  < LOD  < LOD  46 (7.6) 
35–56 
40 (9.5) 
25–50 
Each  value  is  represented  as  mean  with  standard  deviation  (in  brackets)  and  range.  LOD,  limit  of  detection.  Cotton 
MON 15947 derives from genetic segregation of cotton MON 15985. 
3.1.5.  Inheritance and stability of inserted DNA
31 
The genetic stability of the MON 531 and MON 15947 inserts was investigated by Southern analysis. 
The presence of the internal sequence and the flanking regions of the functional insert in MON 531 
and of the flanking regions in MON 15947 indicates stable inheritance over several generations. The 
non-functional insert of the MON 531 event was not retained in the backcrossed lines
32. 
The expected inheritance ratio for the Cry2Ab2 protein  was observed over several selfed generations 
and over successive backcross generations, indicating the presence of a stable single Mendelian locus. 
The phenotypic stability of Cry1Ac, Cry2Ab2, NPTII and β-D-glucuronidase expression was shown 
by  ELISA  measurements  of  the  proteins  in  leaves  and  seeds  of  plants  cultivated  from  several 
generations in different locations. 
The possibility of a lack of co-inheritance of MON 531 and MON 15947 inserts in seeds derived from 
cotton MON 15985 cannot be excluded. However, the EFSA GMO Panel is of the opinion that, even 
though plants containing the MON 15947 insert have not been assessed as a single event (with the 
exception  of  expression  data  provided  as  additional  information),  plants  containing  only  the 
MON 15947  insert  would  not  give  rise  to  an  issue  that  would  require  further  investigations. 
Furthermore, cotton is predominantly a self-pollinator, and cotton MON 15985, as assessed in this 
application, is homozygous for both inserts
33. Therefore, the produced and imported cottonseed of this 
GM cotton will contain all traits, and segregants are expected at only very low frequency. 
Molecular characterisation data gave no indication of interaction between the combined MON 531 and 
MON 15947 inserts, and therefore did not identify issues that would require further investigations. 
3.2.  Conclusion 
The molecular characterisation data establish that cotton MON 15985 contains two inserts containing 
the  cry1Ac,  nptII,  cry2Ab2  and  uidA  expression  cassettes.  Bioinformatic  analyses  of  the  ORFs 
spanning the junction sites within the inserts or between the inserts and genomic DNA did not give 
rise to safety issues. The stability of the inserted DNA and the expression of newly introduced proteins 
was confirmed over several generations. Protein levels were obtained and reported adequately. The 
potential impacts of the protein levels quantified in field trials carried out in the USA are assessed in 
the sections on food/feed safety assessment (Section 5) and ERA (Section 6). 
                                                       
31 Technical dossier, Section D5. 
32 Additional information: 19/05/2009. 
33 Technical dossier, Section A6. Scientific Opinion on genetically modified cotton MON 15985  
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4.  Comparative analysis 
4.1.  Evaluation of relevant scientific data 
4.1.1.  Summary of the previous evaluation of event MON 531 
Compositional data for cotton MON 531 and its conventional counterpart (1992 and 1993: Coker 312; 
1999: DP5415) were generated in field trials carried out in the USA in 1992, 1993 and 1999. The field 
trials performed in 1999 included, in addition to cotton MON 531 and its conventional counterpart, 
non-GM commercial cotton varieties. Cottonseed produced in 1993 was processed into toasted meal 
and  refined  cottonseed  oil  fractions  and  analysed  for  composition.  Significant  differences  in 
cottonseeds were observed for myristic acid, stearic acid and oleic acid (1992), glutamic acid, valine, 
methionine, isoleucine, tyrosine, lysine and histidine (1993) and total fat, carbohydrates, palmitic acid, 
linoleic acid, calcium and iron (1999). However, these differences were not consistent and were found 
for only some growing seasons. 
Information  on  agronomic  performance  and  phenotypic  characteristics  of  cotton  MON 531  was 
derived from field trials performed in 1998 and 1999 in the USA. These studies showed significantly 
more cracked bolls in cotton MON 531 than in its conventional counterpart, possibly related to minor 
differences in insect damage. Other agronomic or phenotypic characteristics did not differ between 
cotton MON 531 and its conventional counterpart. 
The analyses carried out on cotton MON 531, its conventional counterpart and other non-GM cotton 
varieties indicated that cotton MON 531 did not show any compositional, phenotypical or agronomical 
differences from its conventional counterpart that would lead to a need for further assessment. The 
comparative  analysis  of  cotton  MON 531  therefore  provided  no  indication  of  unintended  effects 
resulting from the genetic modification that would give rise to a safety concern (EFSA GMO Panel, 
2011b). 
4.1.2.  Choice of comparator and production of material for the comparative assessment
34 
Cotton MON 15985 was compared with its conventional counterpart cotton, DP50, during field trials 
in the USA in the years 1998, 1999 and 2007. The results of the studies carried out in 1998 and 1999 
have been published (Hamilton et al., 2004). 
Table 2:   Overview of comparative assessment studies with cotton MON 15985 
Study focus  Endpoints  Study details  Conventional 
counterpart 
Non-GM 
cotton 
varieties 
Agronomic  and 
phenotypic 
characteristics 
and/or  composition 
of harvested seeds  
Various 
endpoints  (see 
Sections  4.1.3 
and 4.1.4) 
1998, eight locations in the 
USA 
(a), 35 
1 (DP50)  8 
1999,  six  locations  in  the 
USA 
(b) 
1 (DP50)  15 
2007, five locations in the 
USA
36 
1 (Giza-90)  8 
(a):  In addition, the parental line MON 531 was also included. 
(b):  Field trials were used only for the compositional analysis. 
In the 1999 field trials, cotton MON 15985 (with a G. hirsutum background) and its conventional 
counterpart, DP50, were grown in six locations in the USA. Since cotton MON 15985 was established 
                                                       
34 Technical dossier, Section D7.2; additional information: 18/01/2010 on EFSA-GMO-RX-MON15985. 
35 Technical dossier, Section D7.2. 
36 Additional information: 12/03/2012. Scientific Opinion on genetically modified cotton MON 15985  
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by re-transformation of callus tissue derived from cotton MON 531 in a G. hirsutum DP50 genetic 
background, and subsequently backcrossed with DP50, the EFSA GMO Panel considers DP50 as a 
suitable  conventional  counterpart  for  cotton  MON 15985.  At  all  locations,  two  to  four  non-GM 
commercial cotton varieties were included (in total, 15 non-GM varieties
37). At each site, all test 
materials, were planted using a randomised complete block design with four replications. 
In the 2007 field trials, cotton  MON 15985 (in a  G. barbadense background) and its conventional 
counterpart, Giza-90 (with similar genetic background), were grown in a randomised complete block 
design with three replicates at five locations, representing the major cotton-growing areas of the USA. 
In addition, eight different non-GM commercial varieties (four at each site) were included in the field 
trials. Acid-delinted cottonseed from all test material was used for the compositional analysis. 
The  application  also  included  reports  from  a  study  performed  in  the  USA  in  1998  with  cotton 
MON 15985  and  its  conventional  counterpart,  DP50,  the  parental  line,  MON 531  and  various 
commercial cotton varieties grown in eight locations for analysis of composition of seed and processed 
seed fractions
38, the outcomes of which are further discussed in Section 5.1.2, as well as phenotypic 
and agronomic characteristics.  The starting seed   material for  MON 15985  and the conventional 
counterpart used in this study were produced  under different environmental conditions, which may 
have  affected  seed  quality
39.  Given  that  differences  in  seed  quality,  unrelated  to  the  genetic 
transformations, would affect the outcome of the comparative assessment, t he EFSA GMO Panel 
considers that data obtained from the 1998 study cannot be used to identify potential effects of the 
genetic modification. 
At the request of the EFSA GMO Panel, the applicant provided addi tional information on field trials 
carried out in Brazil and India
40. In Brazil, cotton MON 15985 was compared with the conventional 
counterpart and various commercial varieties in three locations during the 2005/2006 growing season. 
In India, the agronomic and phenotypic characteristics of several varieties containing the MON 15985 
and  MON 531  events and the correspond ing non-GM varieties were studied for agronomic and 
phenotypic characteristics during two years (2002, 2003) and for compositional characteristics during 
a single year (2002). These studies were considered as only confirmatory owing to the limited number 
of locations in Brazil  and  also  the limited description of the field trial design and the lack of 
appropriate statistical analysis for the Indian trials.  The current assessment focuses on data obtained 
from the 1999 and 2007 field studies. 
4.1.3.  Agronomic traits and GM phenotype
41 
In  the  2007  field  trials,  42  agronomic  and  phenotypic  characteristics
42 were compared between 
MON 15985  and its conventional counterpart Giz a-90. In the combined -site analysis significant 
                                                       
37 Including also the parental non-GM line DP50 (from a different seed lot than the conventional counterpart DP50). 
38 Seeds from nine commercial lines, including four non-GM and five GM cotton lines, were supplied as reference lines for 
the compositional comparison but these data were not used by the EFSA GMO Panel because the lines had been grown in 
field trials other than those for the GMO and the conventional counterpart, during the same season. 
39 Additional information: 05/11/2012. 
40 Additional information: 11/11/2013. 
41 Technical dossier, Section D7.4. 
42 Average number of  immature seeds/boll,  average number of  mature seeds/boll,  average number of seeds/boll,  average 
number of vegetative bolls/plant, average total number of main stem nodes/plant, average weight per boll (g), boll retention 
at P1 (position 1) of nodes 4–9 (%), boll retention at P1 of nodes 10–14 (%), boll retention at P1 of nodes 15–19 (%), boll 
retention at P1 of nodes 20–26 (%), boll retention at P2 (position 2) of nodes 4–9 (%), boll retention at P2 of nodes 10–14 
(%), boll retention at P2 of nodes 15–19 (%), boll retention at P2 of nodes 20–26 (%), fibre elongation (%), fibre length 
(inches), fibre micronaire (mic units), fibre strength (g/tex), fibre uniformity (%), height (inches), nodes above cracked boll 
(NACB) observation 1 (no of nodes), NACB observation 2 (no of nodes), NACB observation 3 (no of nodes), nodes above 
white flower (NAWF) observation 1 (no of nodes), NAWF observation 2 (no of nodes), NAWF observation 3 (no of 
nodes), percentage of total bolls that are abnormal (%), plant height at four weeks (inches), plant height at eight weeks 
(inches), plant viguor at four weeks (rating 1–9), plant vigour at eight weeks (rating 1–9), seed cotton yield (pounds/acre), 
seed index of 100 ginned seed (g), stand count at two weeks, stand count at four weeks, total abnormal position 1 (P1) 
bolls, total abnormal position 2 (P2) bolls, total bolls on plant, total normal P1 bolls, total normal P2 bolls, total P1 bolls, 
total P2 bolls. Scientific Opinion on genetically modified cotton MON 15985  
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differences were observed for fibre elongation (11.0 % (MON 15985) vs. 11.6 % (Giza-90)), fibre 
uniformity (84.0 (MON 15985) vs. 82.6 % (Giza-90)) and fibre height (3.07 cm (MON 15985) vs. 
2.97 cm (Giza-90)). The mean values for both cotton MON 15985 and its conventional counterpart 
were outside the range of the commercial non-GM varieties. However, the observed differences fell 
within  the  range  of  values  for  conventional  G.  barbadense  reported  in  the  literature  (Percy  and 
Turcotte, 1992)
43. 
The  EFSA  GMO  Panel  could  not  complete  the  assessment  of  the  agronom ic  and  phenotypic 
characteristics of cotton  MON 15985 on the basis of data provided (a single season and  fewer than 
eight sites (EFSA, 2006a; EFSA GMO Panel , 2011a)). Therefore, the EFSA GMO Panel  could not 
conclude on the potential occurrence of unintended effects based on the outcome of the agronomic and 
phenotypic analysis. 
The relevance for the ERA is further discussed in Section 6.1.2.1. 
4.1.4.  Compositional analysis
44 
The design of the field trials to produce material for the comparative compositional assessment of 
cotton MON 15985 is summarised in Table 2 (see Section 4.1.2). 
In  the  field  trials  in  1999,  seeds  of  cotton  MON 15985,  its  conventional  counterpart  and  the 
commercial non-GM cotton varieties were assessed for 49 parameters
45,46. The statistical analysis of 
compositional  data  from  1999  identified  significantly  increased  levels  of  dihydrosterculic  acid, 
calcium and the fatty acids myristic acid, stearic acid and arachidic acid, as well as decreased levels of 
gossypol (free and total), the fatty acids palmitic acid and linoleic acid, copper, iron, phosphorus and 
potassium in cotton MON 15985 (Table 3). 
In the 2007 field trials, acid-delinted seeds of cotton MON 15985, its conventional counterpart and the 
commercial  non-GM  cotton  varieties  were  assessed  for  65  parameters
47.  More than 50 %  of the 
analytical values for 13 fatty acids were below the limit of quantification (LOQ) and were not included 
in the statistical analyses
48. Therefore, only 52 endpoints were statistically analysed.  Significantly 
increased levels of myristic acid, palmitoleic acid and α-tocopherol, as well as decreased levels of 
palmitic acid, were found in cotton MON 15985 (Table 3). 
   
                                                       
43 http://r0.unctad.org/infocomm/anglais/cotton/sitemap.htm#site 
44 Technical dossier, Section D7.1; additional information, 18/01/2010. 
45 The following parameters were analysed: moisture, protein, total fat, ash, carbohydrates, calories, crude fibre, total and free 
gossypol, calcium, copper, iron, magnesium, manganese, phosphorus, potassium, sodium, zinc, sterculic acid, malvalic 
acid, dihydrosterculic acid, behenic acid, arachidic acid, linolenic + gamma-linolenic acid, linoleic acid, stearic acid, oleic 
acid, plamitoleic acid, palmitic acid, pentadecanoic acid, myristic acid, aspartic acid, threonine, serine, glutamic acid, 
proline,  glycine,  alanine,  cystine,  valine,  methionine,  isoleucine,  leucine,  tyrosine,  phenylalanine,  histidine,  lysine, 
arginine, tryptophan. 
46 Although not endogenously produced by cotton, the seeds were also analysed for aflatoxins. 
47 The following parameters were analysed:  protein, total fat, ash, moisture and carbohydrate (calculated), fibre fractions 
(acid detergent fibre (ADF), neutral detergent fibre (NDF) and total dietary fibre (TDF), crude fibre), 9 minerals, 18 amino 
acids, 25 fatty acids, α-tocopherol, anti-nutrients (total gossypol, free gossypol) and calories (calculated). 
48 10:0  Capric  acid, 12:0  lauric  acid, 14:1  myristoleic  acid,  15:0  pentadecanoic  acid, 15:1  pentadecenoic  acid, 17:0 
heptadecanoic acid, 17:1  heptadecenoic acid, 18:3  gamma-linolenic acid, 20:1  eicosenoic acid, 20:2  eicosadienoic acid, 
20:3 eicosatrienoic acid, 20:4 arachidonic acid, 8:0 caprylic acid. Scientific Opinion on genetically modified cotton MON 15985  
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Table 3:   Compositional  endpoints  in  cotton  seeds  harvested  from  field  trials  with  cotton 
MON 15985  and  its  conventional  counterpart  (DP50  in  1999  and  Giza-90  in  2007)  for  which  a 
statistically significant difference was observed in the across-site analysis 
Parameter  Conventional 
counterpart 
MON 15985  Commercial non-GM 
varieties (range min.–
max. values) 
Field trials in 1999 
14:0 Myristic acid (% total FA)  0.99 ± 0.06  1.12 ± 0.06  0.55–1.28 
16:0 Palmitic acid (% total FA)  25.08 ± 0.33  24.84 ± 0.33  21.23–26.45 
18:0 Stearic acid (% total FA)  2.19 ± 0.053  2.49 ± 0.05  1.99–2.48 
18:2 Linoleic acid (% total FA)  53.39 ± 0.73  53.08 ± 0.73  49.90–56.88 
20:0 Arachidic acid (% total FA)  0.28 ± 0.01  0.29 ± 0.01  0.25–0.33 
Dihydrosterculic acid C19 (% total FA)  0.15 ± 0.01  0.17 ± 0.01  0.13–0.24 
Calcium (% DW)  0.13 ± 0.01  0.13 ± 0.01  0.10–0.16 
Copper (mg/kg DW)  7.07 ± 0.91  6.70 ± 0.91  3.54–11.14 
Iron (mg/kg DW)  49.96 ± 1.63  46.58 ± 1.64  40.58–56.54 
Phosphorus (% DW)  0.69 ± 0.02  0.65 ± 0.02  0.60–0.84 
Potassium (% DW)  1.09 ± 0.02  1.06 ± 0.02  0.98–1.14 
Free gossypol (% DW)  0.87 ± 0.04  0.82 ± 0.04  0.53–1.20 
Total gossypol (% DW)  0.99 ± 0.05  0.92 ± 0.05  0.57–1.42 
Field trials in 2007 
14:0 Myristic acid (% total FA)  0.70 ± 0.03  0.79 ± 0.03  0.49–0.78 
16:0 Palmitic acid (% total FA)  23.22 ± 0.57  22.35 ± 0.56  20.45–24.35 
16:1 Palmitoleic acid (% total FA)  0.77 ± 0.02  0.82 ± 0.02  0.60–0.81 
α-Tocopherol (mg/kg DW)  63.72 ± 11.24  77.71 ± 11.07  29.64–99.98 
Values are reported on a dry-weight basis. The mean values with standard error are given. 
DW, dry weight; FA, fatty acids. 
For all parameters showing differences, the average values fell within the range of commercial non-
GM  cotton  varieties  grown  in  the  same  field  trials,  with  the  exception  of  stearic  acid  in  1999, 
palmitoleic acid in 2007 and myristic acid in 2007 (Table 3). Given the magnitude of these changes 
and the characteristics of these endpoints, the EFSA GMO Panel concludes that compositional data 
give  no  indication  that  the  genetic  modification  induces  unintended  effects  for  which  further 
assessment is needed. 
The EFSA GMO Panel considered the total set of compositional data supplied and the outcome of the 
statistical analysis comparing cotton MON 15985, its conventional counterparts and the set of non-GM 
cotton varieties in the field trials carried out in 1999 and 2007. The EFSA GMO Panel concludes that 
compositional data give no indication that the genetic modification induces unintended effects for 
which further assessment is needed. 
4.2.  Conclusion 
No differences in compositional data between cotton MON 15985 and its conventional counterpart 
necessitating further assessment with regard to safety were identified. The EFSA GMO Panel could 
not complete the assessment of the agronomic and phenotypic characteristics of cotton MON 15985 on 
the basis of data provided (a single season and fewer than eight sites (EFSA, 2006a; EFSA GMO 
Panel, 2011a)). Therefore, the EFSA GMO Panel could not conclude on the potential occurrence of 
unintended effects based on the outcome of the agronomic and phenotypic analysis. Scientific Opinion on genetically modified cotton MON 15985  
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5.  Food/feed safety assessment 
5.1.  Evaluation of relevant scientific data 
5.1.1.  Summary of the previous evaluation of event MON 531 
Cotton MON 531 expresses the Cry1Ac and NPTII proteins. E. coli-produced Cry1Ac and NPTII 
proteins were used for the safety studies after it had been demonstrated that they are equivalent to 
those expressed in cotton MON 531. The newly expressed Cry1Ac and NPTII proteins induced no 
adverse  effects  in  acute  oral  toxicity  studies  in  mice  at  high  dose  levels  and  they  were  rapidly 
degraded  by  proteolytic  enzymes  in  in  vitro  studies,  and inactivated  during  processing  to  toasted 
cottonseed meal. The amino acid sequence of the newly expressed Cry1Ac and NPTII proteins did not 
show any significant similarity with the amino acid sequences of known toxins or allergens. The 
EFSA  GMO  Panel  concluded  that  cotton  MON 531  is  as  safe  and  nutritious  as  its  conventional 
counterpart, and that the overall allergenicity of the whole plant is not changed. Cotton MON 531 and 
its derived products are not expected to have any adverse effects on human and animal health in the 
context of their intended uses (EFSA GMO Panel, 2011b). 
5.1.2.  Effect of processing
49 
Refined oil (i.e. bleached and deodorised oil) was produced from the cottonseeds harvested in the 
1998 season and analysed for its contents of fatty acids, α-tocopherol and gossypol, whilst toasted 
meal  was  analysed  for  gossypol  only.  Since  data  from  the  1998  field  trial  were  rejected  for  the 
comparative assessment, those results were not further considered. 
No  differences  in  compositional  data  of  cotton  MON 15985  and  its  conventional  counterpart 
necessitating further assessment with regard to safety were identified except for the introduced trait 
(see  Section  4.2).  The  EFSA  GMO  Panel  considered  that  the  effect  of  processing  on  cotton 
MON 15985 is not expected to be different from the effect on conventional cotton varieties. 
5.1.3.  Toxicology
50 
Cotton MON 15985 expresses four new proteins: Cry1Ac, NPTII, Cry2Ab2 and GUS E377K. Cry1Ac 
and NPTII proteins have been previously assessed for safety in connection with the risk assessment of 
cotton  MON 531  (EFSA  GMO  Panel,  2011b),  from  which  MON 15985  was  obtained  by 
retransformation. In addition, the safety of NPTII has previously been assessed by the EFSA GMO 
Panel in other GM crops (EFSA, 2004a, b, 2006c; EFSA GMO Panel, 2010c, 2012). The safety of a 
Cry2Ab2 protein with an almost identical amino acid sequence also has been previously assessed by 
the EFSA GMO Panel for maize MON 89034 (EFSA, 2008). 
5.1.3.1.  Proteins used for safety assessment 
Given the low expression levels of the Cry2Ab2 protein in the GM crop and the consequent difficulty 
in extracting sufficient protein from the GM cotton, the protein was produced in a GM B. thuringiensis 
strain,  EG7699.  For  equivalence  testing,  plant-derived  Cry2Ab2  protein  was  obtained  from  both 
cotton MON 15985 and a second cotton, MON 15813, obtained using the same transformation vector 
as for MON 15985. The MON 15813 source was chosen because of easy extraction of the Cry2Ab2 
protein in sufficient amounts for experimental purposes to corroborate equivalence testing
51. Proteins 
were purified by chromatographic methods. Cry2Ab2 from leaves of  MON 15985 and MON 15813, 
and from  B. thuringiensis, displayed immunoreactive bands corresponding to proteins of the same 
molecular size (62 to 63 kDa). In addition, Cry2Ab2 from MON 15813 and its bacterial analogue both 
reacted negatively in the glycosylation assay and had similar  half-minimal effective concentration 
(EC50) values in the insect bioassay on larvae of  Helicoverpa zea. Cry2Ab2 proteins from cotton 
MON 15813  and  from  B.  thuringiensis  were  further  characterised  by  matrix-assisted  laser 
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desorption/ionisation-time-of-flight  (MALDI-TOF)  after  tryptic  digestion  by  reverse  phase  high-
performance  liquid  chromatography  (HPLC)  followed  by  mass  spectrometry  (quadrupole-time-of-
flight (Q-TOF)) of column eluates containing separated peptides, and by N-terminal sequencing of the 
peptides in two selected fractions collected after elution. The peptides thus identified corresponded to 
the cleavage products derived from the sequence of the Cry2Ab2 protein. The EFSA GMO Panel 
accepts the use of the microbe-derived Cry2Ab for safety tests. 
The GUS E377K protein expressed in cotton MON 15985 was extracted from cottonseeds and purified 
by ion exchange chromatography. The identity of the purified protein was determined by sodium 
dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by Western blotting, N-
terminal sequencing of four peptide bands observed on SDS-PAGE and by MALDI-TOF after tryptic 
digestion. In addition, the purified protein preparation was tested for β-glucuronidase activity. Of the 
protein bands observed in the SDS-PAGE, two, with apparent molecular weights of 72 and 148 kDa, 
were identified as GUS proteins, whilst another band with apparent molecular weight of 52 kDa was 
identified as alanine aminotransferase. A fourth faint band (36 kDa) could not be identified. The two 
bands that were identified as GUS were also reactive in Western blots. The peptides identified through 
MALDI-TOF mass spectrometry of the trypsin cleavage products of these two bands corresponded to 
the sequence of GUS E377K, indicating that the protein in the higher-molecular-weight band, with 
apparent molecular weight of 148 kDa, was probably a dimer of the monomer in the band with an 
apparent weight of 72 kDa. The protein preparation also exhibited β-glucuronidase activity. The GUS 
E377K protein expressed in cotton MON 15985 is not glycosylated. 
5.1.3.2.  Toxicological assessment of newly expressed proteins in cotton MON 15985 
The GUS E377K protein expressed in cotton MON 15985 is a β-glucuronidase, a family of enzymes 
widely distributed in nature, including humans. The particular enzyme under scrutiny is derived from 
E. coli K12, a common inhabitant of the gastrointestinal tract in vertebrates. 
(a) Acute toxicity 
In an acute oral toxicity study in CD-1 mice, the Cry2Ab2 protein from B. thuringiensis did not induce 
adverse effects up to the maximum dose of 1 450 mg/kg body weight. No adverse effects were seen 
for the GUS protein at the highest dose of 100 mg/kg body weight tested under the same conditions. 
The EFSA GMO Panel considers that acute toxicity testing of the newly expressed proteins is of little 
value for the risk assessment of the repeated human and animal consumption of food and feed derived 
from GM plants. 
(b) In vitro degradation by proteolytic enzymes 
The  resistance  to  degradation  by  pepsin  of  the  Cry2Ab2  and  of  the  GUS  E377K  proteins  was 
investigated in solutions at pH ≈ 1.2 in two independent studies. The integrity of the test proteins in 
probes taken at various time points was analysed by SDS-PAGE followed by protein staining. In the 
case of Cry2Ab2, the integrity of the protein was also analysed by Western blotting. The Cry2Ab2 
protein was degraded by pepsin within 15 seconds. The GUS E377K full-length protein was degraded 
by pepsin within 15 seconds. Proteolytic fragments of GUS E377K were reported to be degraded by 
pepsin within four minutes. 
(c) Bioinformatic studies 
Bioinformatic analyses of the amino acid sequences of the Cry1Ac, NPTII, Cry2Ab2 and GUS E377K 
proteins in cotton MON 15985 revealed no significant similarities to known toxic proteins
52. 
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5.1.3.3.  Toxicological assessment of new constituents other than proteins 
No  new  constituents,  other  than  the  Cry1Ac,  Cry2Ab2,  NPTII  and  GUS  E377K  proteins,  are 
expressed in cotton MON 15985 and no biologically relevant changes in the composition of cotton 
MON 15985 were detected in the comparative compositional analysis (see Section 4.1.4). 
5.1.3.4.  Toxicological assessment of the whole GM food/feed
53 
(a) Sub-chronic toxicity study 
The applicant provided a repeated -dose 90-day feeding study in rats with ground cottonseed of 
MON 15985, the conventional counterpart (DP50) and six non-GM commercial cotton varieties. 
Twenty rats (Crl:CD®(SD)IGS BR) of each sex received one of 10 experimental diets. Two of these 
diets contained ground cottonseed of MON 15985, PCR-confirmed, at inclusion levels of 2 % and 5 % 
(w/w). Two other diets contained the corresponding amounts of control ground cottonseed DP50, and 
the six remaining diets 5 % (w/w) ground cottonseed of commercial non-GM cotton varieties
54. The 
test material was added to a standard rodent diet. 
Feed intake, body weight and clinical abnormalities were recorded. Interim (week 5) and terminal 
(week 14) clinical chemistry, haematology and u rine analyses were performed on  10 animals per 
sex/group. Post-mortem measurements included organ weight determinations, gross pathology and 
histopathology on control and high-dose rats. 
Two mortalities occurred during the experiment, one in the 5 % control group and the other in one of 
the six reference groups. Feed intake and body weight gain were comparable in the test and the control 
group. Several significant differences were observed between the test and the control group in 
haematology, clinical chemistry and urine analyses. These differences were not dose related, occurred 
at only one time point and in one sex and/or fell within the range of reference groups. No significant 
differences in absolute and relative organ weights were observed. Macroscopic   examination and 
histopathology of selected tissues and organs revealed no test-substance-related changes. 
The EFSA GMO Panel concludes that there were no indications of adverse effects after administration 
of diets containing ground cottonseed of MON 15985 up to the 5 % inclusion level. 
(b) Animal feeding study 
The  applicant  provided  a  feeding  stud y
55  with  channel  catfish  ( Ictalurus  punctatus)  fed  diets 
containing meal from GM cotton MON 15985, the conventional counterpart (DP50), the parental GM 
commercial line MON 531 (DP50B), MON 15813 (another GM cotton line expressing the Cry2Ab2 
protein) and two commercial non-GM cotton reference varieties (ST474, DP1266) at a 20 % inclusion 
level. For each treatment, 100 catfish were used, divided over  5 aquaria with 20 fish each. Feed 
consumption was measured and behavioural observations were made daily, whereas body weights 
were  measured  only  at  the  beginning  of  the  experiment,  after  four  weeks  and  at  the  end  of  the 
experiment of eight weeks. After the experiment, five fish per aquarium were used to prepare fillets, 
which were pooled for compositional analysis (moisture, crude protein, crude fat, ash), yielding five 
pooled fillet samples per treatment group. 
The feed consumption, weight gain, feed conversion ratio, visceral fat (% of body weight), fillet 
composition, survival and behaviour of fish fed the diet containing meal of cotton MON 15985 did not 
significantly differ from those of fish fed the other diets. Consequently, this experiment produced no 
evidence of unintended effects. 
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5.1.4.  Allergenicity 
The strategies to assess the potential risk of allergenicity focus on the source of the recombinant 
protein, on the potential of the newly expressed protein to induce sensitisation or to elicit allergic 
reactions  in  already  sensitised  persons  and  on  whether  the  transformation  may  have  altered  the 
allergenic properties of the modified plant. 
5.1.4.1.  Assessment of allergenicity of the newly expressed proteins 
A weight of evidence approach is followed, taking into account all of the information obtained with 
various test methods, since no single experimental method yields decisive evidence for allergenicity 
(Codex Alimentarius, 2009; EFSA, 2006a; EFSA GMO Panel, 2010b). 
The genes coding for the newly expressed Cry1Ac, Cry2Ab2, NPTII and GUS E377K proteins in 
cotton MON 15985 derive from B. thuringiensis and E. coli, which are not considered to be common 
allergenic sources. 
Bioinformatic  analyses
56 of the amino acid sequenc es of the  Cry1Ac, Cry2Ab2, NPTII and GUS 
E377K proteins  using the criterion of 35  % identity in a window of 80 amino acids revealed no 
significant similarities to known allergens. In addition, the applicant performed analyses  searching for 
matches of eight contiguous identical amino acid sequences between these newly expressed proteins 
and known allergens, which confirmed the outcome of the above-mentioned bioinformatic analyses 
showing no similarities to known allergens. 
The studies on resistance to degradation by proteolytic enzymes presented in the current application 
have been described in Section 5.1.3.2. 
The  EFSA  GMO  Panel  has  previously  evaluated  the  safety  of  the  Cry1Ac,  Cry2Ab2  and  NPTII 
proteins in the context of several other applications and no concerns about allergenicity were identified 
(e.g. EFSA, 2004a, b, 2006c, 2008; EFSA GMO Panel, 2010c, 2011b, 2012). 
The EFSA GMO Panel considered that there are no indications that the newly expressed Cry1Ac, 
Cry2Ab2,  NPTII  and  GUS  E377K  proteins  in  cotton  MON 15985  may  be  allergenic  under  the 
intended conditions of use. In addition, based on current knowledge and since none of the newly 
expressed proteins showed allergenicity, no concerns regarding the mixture of these newly expressed 
proteins in cotton MON 15985 affecting allergenicity are expected. 
With regard to adjuvanticity, Bt proteins have been suggested to possess adjuvant activity, based on 
animal studies on Cry1Ac (e.g. Vazquez-Padron et al., 1999; Moreno-Fierros et al., 2003; Rojas-
Hernandez et al., 2004). However, at present, there is no evidence for Bt protein adjuvanticity of 
safety concern among the GM plants assessed so far by the EFSA GMO Panel (EFSA, 2009a; EFSA 
GMO Panel, 2011b, c). In relation to the NPTII and GUS E377K proteins, no concerns regarding 
adjuvanticity were identified in the scientific literature or in the data provided by the applicant. The 
expression levels of the newly expressed proteins in cotton MON 15985 are similar to those in cotton 
MON 531 and MON 15947 (see Section 3.1.4). In addition, there is no information available on the 
structure or function of the newly expressed Cry1Ac, Cry2Ab2, NPTII and GUS E377K proteins that 
would suggest an adverse adjuvant effect of their mixture in cotton MON 15985 under the intended 
conditions of use. 
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5.1.4.2.  Assessment of allergenicity of the whole GM plant 
Cotton is not considered to be a common allergenic food (OECD, 2009)
57. A few cases of food allergy 
to cottonseed have been reported (Atkins, 1988; Malanin and Kalimo, 1988; O‘Neil and Lehrer, 1989; 
de Olano et al., 2009; Mane et al., 2013), all of which were related to foods in which cottonseed flour 
was  the  offending  ingredient.  However,  the  main  cottonseed  product  in  human  food,  industrially 
processed cottonseed oil, is highly purified and contains negligible levels of proteins. Furthermore, the 
protein level in cellulose from cottonseed linters for food use is very low. 
In the context of this application, and considering the data from the molecular characterisation, the 
compositional analysis and the assessment of the newly expressed proteins, the EFSA GMO Panel 
identified no indications of safety concern regarding the overall allergenicity of cotton MON 15985. 
5.1.5.  Nutritional assessment of GM food/feed 
The intended trait of cotton MON 15985 is insect resistance, with no intention to alter nutritional 
parameters. The outcome of the compositional analysis (see Section 4.1.4) confirmed the nutritional 
adequacy of the food and feed products (cottonseed, refined oil and toasted cottonseed meal) derived 
from  cotton  MON 15985.  The  introduction  of  these  products  into  the  food  and  feed  supply  is, 
therefore, not expected to have any nutritional impact, similar to its conventional counterpart and non-
GM cotton varieties. 
The nutritional similarity of cotton MON 15985 to commercial non-GM cotton varieties, indicated by 
compositional  data,  was  corroborated  by  a  study  with  MON 15985  in  catfish
58 and a number of 
published feeding studies with this cotton in dairy cattle (Castillo et al., 2004), chickens (Mandal et al., 
2004) and quails (Hamilton et al., 2004). 
The EFSA GMO Panel concludes that the data provided support the view that  diets formulated with 
cottonseed meal derived from MON 15985 are as nutritious as those formulated with cottonseed meal 
derived from commercial non-GM cotton varieties. 
5.1.6.  Post-market monitoring of GM food/feed 
The  EFSA  GMO  Panel  considers  that  post-market  monitoring  of  GM  food/feed  from  cotton 
MON 15985 is not necessary. 
5.2.  Conclusion 
The newly expressed proteins in cotton MON 15985 do not give rise to safety concerns for human and 
animal  health,  since  no  adverse  effects  in  the  available  studies  were  observed  and  no  structural 
similarities  to  known  toxins  were  detected.  Similarly,  the  EFSA  GMO  Panel  did  not  identify 
indications  of  safety  concerns  regarding  allergenicity  or  adjuvanticity  with  the  newly  expressed 
proteins in cotton MON 15985. The cotton MON 15985 is as nutritious as its conventional counterpart 
and non-GM commercial varieties. 
The EFSA GMO Panel concludes that cotton MON 15985 is as safe and nutritious as its conventional 
counterpart and that it is unlikely that the overall allergenicity of the whole plant is changed. 
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6.  Environmental risk assessment and monitoring plan 
6.1.  Evaluation of relevant scientific data 
The scope of applications EFSA-GMO-UK-2008-57 and EFSA-RX-MON15985 includes G. hirsutum 
and G. barbadense
59 and covers cotton MON 15985 for food and feed uses, import and processing, 
food additives produced from cotton MON 15985 and feed produced from cotton MON 15985 (feed 
materials and feed additives) but does not include cultivation
60. Considering the intended uses of 
cotton MON 15985, the ERA is concerned mainly with ingestion by an animal leading to exposure of 
bacteria within its gastrointestinal tract, and to exposure of soil bacteria from  the faecal material of 
such an animal,  and  with the accidental release into the environment of viable seeds of cotton 
MON 15985 (e.g. during transport and/or processing). 
Cotton MON 15985 has been developed by re-transformation via a biolistic system of cotton event 
MON 531 (see Sections 3.1.2 and 3.1.4) with the event  MON 15947 to confer resistance to certain 
lepidopteran pests by the expression of the  B. thuringiensis-derived Cry1Ac and Cry2Ab2 proteins, 
respectively. 
6.1.1.  Evaluation of transformation events in cotton MON 15985 
In its previous scientific opinions, the EFSA GMO Panel was of the opinion that the single cotton 
events MON 531 is as safe as its conventional counterpart, and that the placing on the market of cotton 
MON 531 for food and feed uses, import and processing is unlikely to have an adverse effect on 
human or animal health, or on the environment (EFSA GMO Panel, 2011b). Furthermore, PMEM 
plans  for  cotton  MON 531,  including  general  surveillance,  were  proposed  by  the  applicants  and 
considered in line with the EFSA GMO Panel scientific opinion on PMEM (EFSA, 2006d; EFSA 
GMO Panel, 2011d). 
Event MON 15947 was not previously risk assessed since it was used only in the re-transformation 
process.  The  event  MON 15947  segregates  as  a  single  Mendelian  locus,  as  demonstrated  by  the 
applicant
61. 
A  segregant  line  harbouring  event  MON 15947  only  has  been  derived  from  the  original  re -
transformant MON 15985 for regulatory purposes and, in particular, to analyse protein expression 
data. This information was submitted by the applicant and assessed by the EFSA GMO Panel
62. 
Cotton is predominantly a self-pollinator and cotton MON 15985, as assessed in this application, is 
homozygous for both inserts
63. Therefore, the produced and imported cottonseed of this GM cotton 
will contain all traits, and segregants are expected at  only very low frequency. Should segregation of 
MON 531 and MON 15947 events occur, its possible implications are assessed below. 
6.1.2.  Environmental risk assessment 
6.1.2.1.  Unintended effects on plant fitness due to the genetic modification
64 
Gossypium herbaceum is a highly domesticated crop which has been grown in Southern Europe since 
the 19
th century, giving rise to feral plants which can occasionally be found in the same area (Todaro 
1917; Davis, 1967). From recent available data, it is possible to see that, in the EU, cotton is cultivated 
in Greece and Spain (EUROSTAT, 2013). The main cultivated cotton species (G. hirsutum), which 
has been present in Southern Europe since the 19
th century, is an annual self-pollinator. In the absence 
of insect pollinators (such as wild bees, honeybees, bumblebees), cotton flowers are self-pollinating, 
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but when these pollinators are present low frequencies of cross-pollination can occur (McGregor, 
1959; Moffett and Stith, 1972; Moffett et al., 1975; Van Deynze et al., 2005). 
Pollen and cottonseed dispersal are potential sources of vertical gene flow to cross-compatible wild 
cotton relatives, other cotton varieties and to occasional feral cotton plants. However, in Europe, there 
are no cross-compatible wild relatives with which cotton can hybridise. Because cotton pollen is very 
large  (120–200 µm),  heavy  and  sticky,  wind-mediated  dispersal  of  pollen  to  cross-pollinate  other 
cotton varieties is considered negligible (Vaissiere and Vinson, 1994). In addition, cross-pollination 
percentages rapidly decrease with increasing distance from the pollen source (Umbeck et al., 1991; 
Kareiva et al., 1994; Llewellyn and Fitt, 1996; Xanthopoulos and Kechagia, 2000; Zhang et al., 2005; 
Van Deynze et al., 2005, 2011; Hofs et al., 2007; Llewellyn et al., 2007; Heuberger et al., 2010). 
Seeds  are  the  only  survival  structures.  However,  seed-mediated  establishment  of  cotton  and  its 
survival outside cultivation in Europe are mainly limited by a combination of absence of a dormancy 
phase, low competitiveness and susceptibility to diseases and cold climate conditions (Eastick and 
Hearnden, 2006). Even in regions where cotton is widely grown, such as Australia, the risk of GM 
cotton becoming feral along transportation routes, or a weed on dairy farms where raw cottonseed is 
used as feed, has been shown to be negligible (Addison et al., 2007). In arid areas where cotton is 
cultivated in Europe, adequate soil moisture is an additional factor affecting the survival of feral cotton 
seedlings.  Since  the  limited  data  available  do  not  indicate  any  relevant  change  in  the  general 
characteristics of cotton MON 15985 compared with its conventional counterpart, the inserted insect 
resistance trait is not likely to provide a selective advantage outside cultivation in Europe. If accidental 
spillage  and  subsequent  release  into  the  environment  of  cotton  MON 15985  seeds  occurs,  cotton 
MON 15985 plants would have a selective advantage only under conditions of high infestation by 
susceptible lepidopteran species. Insect resistance against certain lepidopteran pests, such as cotton 
bollworm  (CBW,  Helicoverpa  armigera),  pink  bollworm  (PBW,  Pectinophora  gossypiella)  and 
tobacco budworm (TBW, Heliothis virescens), provides a potential advantage in cultivation under 
infestation conditions, but plant survival is also limited by sensitivity to a range of other environmental 
factors. It is thus considered very unlikely that cotton MON 15985, or its progeny, will differ from 
other  cotton  varieties  in  their  ability  to  survive  until  subsequent  seasons  or  to  establish  feral 
populations under European environmental conditions. 
The applicant presented in the application data gathered over a series of field trials conducted across 
eight locations in the USA in 1998, as described in Section 4.1.2. Information on phenotypic and 
agronomic characteristics was provided to assess the agronomic performance of cotton MON 15985 in 
comparison  with  its  conventional  counterpart,  DP50.  In  particular,  in  the  1998  field  trials,  the 
comparative assessment was conducted comparing the event MON 15985 introgressed into the genetic 
background of the cotton Upland elite cultivar belonging to the G. hirsutum L. species; consequently, 
the event MON 15985 assessed in the 1998 field trials was also G. hirsutum. The 1998 field trials 
presented in the application were statistically re-analysed by the applicant at the request of the EFSA 
GMO Panel
65. The statistical analysis provided was conducted from analysis of data from only four 
sites (out  of seven) because three of the  sites did not have sufficient replicated entries
66. The 
agronomic  and  phenotypic  analysis  identified  seven  statistically  significant  differences  (of  11 
parameters tested) in the across location statistical analysis. Cotton  MON 15985 had a higher stand 
count at 14 and 30 days after planting, a higher number of flowers  at visits 3, 4, 5 and 6 during the 
flowering period and an increased yield than its conventional counterpart. Experimental data provided 
by the applicant showed that seed germination of cotton MON 15985 was in some cases significantly 
lower than that of its  conventional counterpart. The applicant stated that the seed lots were grown 
under different environmental conditions and claimed that this may have affected seed quality
67. Since 
differences in starting seed quality would influence the outcome, the EFSA GMO Panel was not able 
to conclude on the data generated from these studies
68. In the additional information provided by the 
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applicant, data generated during the 2007 growing season in the USA from five sites were analysed
69. 
In this study, the MON 15985 event had been introgressed into the genetic background of Giz a-90 
used as the recurrent parent. Giza-90 is a Pima cotton variety, belonging to the species G. barbadense 
L.  The  number  of  backcrosses  with  the  recurrent  parent  is  expected  to  produce  more  than  99 % 
isogeneity  between  the  MON 15985  and  its  conventional  counterpart.  The  statistical  analysis 
identified  three  phenotypic  significant  differences  (of  42  parameters  tested),  all  related  to  the 
characteristics of the fibres (elongation, uniformity and length). In the 2007 field trials, ecological 
interactions were also assessed, such as the response to abiotic stressors and data on diseases produced 
by fungi and arthropods; for these three categories 8, 10 and 9 endpoints were measured, respectively. 
The analyses of the ecological interactions revealed only one difference between MON 15985 and its 
conventional counterpart, related to the lower damage caused by PBW in the former. This difference 
was expected since the insect-protection trait expressed in MON 15985 is intended to control this pest. 
In accordance with its guidance document on the ERA of GM plants (EFSA GMO Panel, 2010a), the 
EFSA  GMO  Panel  follows  a  weight  of  evidence  approach  in  collating  and  assessing  appropriate 
information from various data sources (e.g. molecular and compositional data, available agronomic 
and phenotypic data from field trials performed by the applicant and the scientific literature) in order 
to assess the likelihood of unintended effects on the environment. The applicant provided molecular 
and compositional data that are assessed by the EFSA GMO Panel in Sections 3 and 4, respectively. In 
addition, the applicant presented and analysed agronomic and phenotypic data gathered from field 
trials with cotton MON 15895 introgressed into the G. hirsutum L. genetic background across four 
locations in the USA in 1998, and five locations in USA in 2007, with the MON 15895 introgressed 
into  the  G.  barbadense  L.  genetic  background.  For  each  site  in  1998  and  2007,  information  on 
phenotypic and agronomic characteristics was provided to assess the agronomic performance of cotton 
MON 15895  in  comparison  with  the  appropriate  conventional  counterpart  (DP50  and  Giza-90, 
respectively). However, as explained above, the 1998 field trials cannot be exploited to assess the 
potential effect of the introduced trait and/or the genetic modification in cotton MON 15985 on the 
agronomic  performance  compared  with  its  conventional  counterparts.  In  response  to  requests  for 
further  information,  the  applicant  submitted  the  comparative  analysis  performed  for  regulatory 
applications in Brazil and India
70. The additional information provided has been assessed by the EFSA 
GMO Panel, but was deemed inappropriate  owing to the limited number of locations in Brazil, the 
limited description of the field trial design for both Brazil and India and the lack of appropriate 
statistical analysis for the Indian trials. Therefore, the EF SA GMO Panel can base its assessment on 
only the field trials performed in 2007, which were conducted in one single growing season and at five 
locations.  However,  the  assessment  of  the  agronomic  and  phenotypic  characteristics  of  cotton 
MON 15985 requires at least two seasons of data according to the applicable guidance document 
(EFSA, 2006a) (see Sections 4.1.2 and 4.2). 
On the basis of the EFSA opinion on  MON 531 (EFSA, 2011b) in which it was indicated that this 
single event does not show altered agronomic and phenotypic performance, as well as the information 
available in the current opinion, the EFSA GMO Panel is of the opinion that, in case of segregation, it 
is unlikely that MON 15947 will express altered agronomic and phenotypic performance. 
In addition to the data presented by the applicant, the EFSA GMO Panel is not aware of any scientific 
report of increased fecundity, persistence (volunteerism) or ferality of GM cotton in regions where it is 
cultivated  (Eastick  and  Hearnden,  2006;  Bagavathiannan  and  Van  Acker,  2008).  There  is  no 
information to indicate change in survival capacity (including over-wintering). 
The  EFSA  GMO  Panel  could  not  complete  the  assessment  of  the  agr onomic  and  phenotypic 
characteristics of cotton MON 15985 on the basis of the data provided (a single season and fewer than 
eight sites (EFSA, 2006a; EFSA GMO Panel 2011a)).  Therefore, the EFSA GMO Panel  could not 
conclude on the potential occurrence of unintended effects based on the outcome of the agronomic and 
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phenotypic analysis. The EFSA GMO Panel concludes that, considering the scope of this application, 
the aforementioned weight of evidence approach and the poor ability of cotton to survive outside 
cultivated  land,  there  is  very  low  likelihood  that  cotton  MON 15985  has  any  enhanced  fitness 
characteristics  that  will  change  its  persistence  and  survival  following  accidental  release  into  the 
environment of viable seeds from cotton MON 15985, except under conditions of infestation by the 
specific lepidopteran pests. 
6.1.2.2.  Potential for gene transfer
71 
A prerequisite for any gene transfer is the availability of pathways for the transfer of genetic material, 
either through horizontal gene transfer (HGT) of DNA, or vertical gene flow via cottonseed dispersal 
and cross-pollination. 
(a) Plant to bacteria gene transfer 
The recombinant DNA inserts in cotton MON 15985 could hypothetically be acquired through HGT 
by bacteria. However, current scientific knowle dge of recombination processes in bacteria indicates 
that horizontal transfer of non -mobile, chromosomally  located DNA fragments between unrelated 
organisms (such as plants to bacteria) does not occur at quantifiable levels (EFSA,  2009b). The 
hypothetical HGT of recombinant plant DNA to bacteria requires a genetic recombination mechanism, 
which, in theory, might be homologous or illegitimate recombination. The exposure of bacteria to the 
recombinant DNA fraction of plants should also be assessed in the cont ext of their continuously 
ongoing exposure to a wide variety of other naturally occurring sources of DNA. 
The probability and frequency of HGT of plant DNA (including the recombinant DNA fraction) to 
exposed bacteria in the environment is determined by the following factors: (1) the amount and quality 
of plant DNA accessible to bacteria in relevant environments; (2) the presence of bacteria with a 
capacity to develop genetic competence for transformation (to take up extracellular DNA); (3) the 
mechanism of genetic recombination by which the plant DNA can be incorporated and thus stabilised 
in the bacterial genome (including chromosomes or plasmids); and (4) the mobility of the plant DNA 
in bacterial recipients (i.e. whether they are located on chromosomes or mobile genetic elements such 
as plasmids). 
Furthermore, the risk assessment of any impact of rare HGT events considers the potential expression 
of the recombinant plant DNA in the bacterial cells and , most importantly, the selective advantage 
conferred by acquisition of recombinant DNA. Finally, the source of the recombinant DNA inserted 
into the GM plant is considered because many plant transgenes have been derived from the genomes 
of various soil bacteria. Information on the prevalence of similar genes and their encoded phenotypes 
within natural microbial communities is taken into account to understand alternative and naturally 
occurring exposure sources to the same genetic traits. 
Hazard identification and characterisation 
Cotton  MON 15985  contains  recombinant  genes  and  regulatory  DNA  sequences  originating  from 
bacteria, i.e. aadA, nptII, oriV, uidA and the nos promoter (see Section 3.1.4). It also contains a 
synthetic  cry1Ac  gene  encoding  for  a  Cry1Ac  variant  protein  with  99.4 %  amino  acid  sequence 
identity to a natural insecticidal Cry1Ac protein of a B. thuringiensis strain and a synthetic cry2Ab2 
gene  encoding  for  a  Cry2Ab  variant  protein  of  a  B.  thuringiensis  strain.  The  uidA,  cry1Ac  and 
cry2Ab2 genes are under the control of a promoter originating from the Cauliflower mosaic virus 
(CaMV) with the duplicated enhancer region (e35S). The nptII gene is under the control of the CaMV 
35S promoter, while the aadA gene is under the control of its own promoter. The transcription of the 
aforementioned  genes  is  under  the  control  of  the  3′  untranslated  region  of  the  nos  gene  from 
A. tumefaciens,  except  the  cry1Ac  gene  that  is  terminated  by  the  soybean  7S  3′  transcriptional 
termination sequence (for further details, see Section 3.1.3). The cry1Ac and cry2Ab2 genes originate 
from B. thuringiensis, and in cotton MON 15985 they are under the control of an enhanced CaMV 
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promoter  mentioned  above.  The  activity  of  the  CaMV  promoters  in  unrelated  organisms  such  as 
bacteria cannot be excluded. 
As described in Section 3.1.1, and as in the study performed within the frame of risk assessment for 
HGT of cotton MON 531 (EFSA, 2011b), bioinformatic analysis indicates the possibility of double 
homologous recombination between the aadA gene and the oriV present in cotton MON 15985 with 
the  same  sequences  present  in  bacterial  plasmids  isolated  from  soil  and  activated  sludge.  This 
homologous recombination would lead to the replacement of the genes in such plasmids between the 
two recombination sites by the nptII gene cassette as present in the DNA of cotton MON 15985 and, 
thus, the acquisition of novel genetic information. The stabilisation rate of the nptII gene cassette in 
such bacteria is estimated from laboratory experiments with comparable constructs to be increased 
about  10
9–10
10  times  compared  with  stabilisation  by  the  process  of  illegitimate  recombination 
encountered for constructs in which no flanking homology to bacterial sequences has been introduced 
(De Vries and Wackernagel, 2002; Hülter and Wackernagel, 2008). 
In  addition  to  the  double  homologous  recombination  involving  flanking  regions  of  transgenes, 
homologous recombination may theoretically also occur between single transgenes and their natural 
counterparts in bacteria, i.e. aadA, uidA, nptII, cry1Ac or cry2Ab2. Such substitutive recombination, 
however, would not lead to the acquisition of additional novel trait, since only nucleotide substitutions 
with existing genes would be expected. The potential for such replacements should be considered in 
the context of naturally occurring homologous recombination, mutations and additions or deletions in 
the bacterial genomes. Therefore, no hazard was identified. 
Furthermore, illegitimate recombination events would also be theoretically possible, but they have not 
been detected even in laboratory studies in which bacteria have been exposed to high concentrations of 
DNA from GM plants (reviewed by EFSA, 2009b) and are therefore not considered to contribute 
significantly to the HGT process. 
Expression of the nptII gene under the control of CaMV 35S promoter has been demonstrated in 
bacteria (Assaad and Signer, 1990; Lewin et al., 1998). Therefore, oral treatment with kanamycin or 
neomycin may create a selective advantage for the transformed bacterial cells with the capability to 
express the nptII-encoded neomycin phosphotransferase II and could enhance further spread of nptII 
between bacteria by transformation or conjugation. The indicated uses of kanamycin or neomycin or 
similar substances include gut irrigation and the treatment of encephalopathy in humans (neomycin) 
and treatment of diarrhoea in farm animals and aerosol administration for respiratory infections in 
humans and animals (EFSA, 2009b). 
This hazard identification and characterisation indicates that HGT of the nptII gene cassette of cotton 
MON 15985  could  lead  to  kanamycin-  and  neomycin-resistant  bacteria  emerging  in  some 
environments, especially in the gastrointestinal tract or faeces of humans and animals receiving diets 
containing  DNA  of  MON 15985,  under  selective  conditions  (i.e.  usage  of  the  corresponding 
antibiotics). 
Exposure characterisation 
DNA  is  a  common  component  of  many  food  and  feed  products  derived  from  plants.  During 
processing,  the  DNA  of  the  plant  material  for  food  and  feed  may  be  substantially  degraded  or 
removed. Considering the scope of these applications (cotton MON 15985 for food and feed uses, 
import and processing, food additives produced from cotton MON 15985, feed produced from cotton 
MON 15985 (feed materials and feed additives); see Terms of reference), products that are covered in 
this application include seeds for feed use, oil for food and feed, meals, cake and hulls for feed, and 
linters and derived products (e.g. viscose, food casings, cellulose esters and ethers) for food. Based on 
the information provided by the applicant and knowledge from the literature it can be expected that 
recombinant DNA is still present in cottonseeds, cottonseed meal and linters. However, DNA was not Scientific Opinion on genetically modified cotton MON 15985  
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detected in methylcellulose or oil
72. Experimental evidence was provided that processing reduced the 
content of transgenic DNA spanning the nptII gene cassette in the cottonseed meal from 1.6 to 5.2 % 
of what is present in unprocessed cottonseed
73. 
In case of products containing recombinant DNA, the main route of exposure to potential bacterial 
recipients is in the gastrointestinal systems of humans or animals. DNA present in food and feed is 
substantially degraded through digestion in the human and animal gastrointestinal tracts (Rizzi et al., 
2012). The highest exposure is expected for cottonseeds and unprocessed linters because they may 
contain intact DNA. Exposure is also possible for products in which the transgenic DNA is more 
degraded but in which DNA of gene length size could still be present. For instance, such DNA is 
expected to be present in only limited quantities in cottonseed meal owing to the effects of processing. 
No exposure is expected from highly processed and refined products, such as cottonseed oil and 
methylcellulose, which covers all products of cotton MON 15985 relevant for human consumption. In 
animal feeding, cotton products are used in only small amounts in the EU (FEDIOL, online), mainly 
because of the presence of gossypol, which is highly toxic to non-ruminants (Verstraete, 2013)
74. Even 
with accepted upper limits of 500 mg/kg gossypol in feed for ruminants
75, the feed source will contain 
only a small percentage of cotton seeds or cottonseed meal. Because of the restricted dietary amounts, 
effects of feed processing and degrad ation in the gastrointestinal tract and faeces, the manure of 
animals fed with cotton MON 15985 will contain only very limited amounts of DNA of gene length 
size. 
Bacteria in soil or surface waters could be exposed to DNA from cotton MON 15985 through manure 
or accidentally by decomposing seeds and decomposing plant material of occasional feral GM cotton 
plants originating from accidental cottonseed spillage during transportation or processing. Compared 
with usage as defined in the scope of this application, such exposure will be highly limited. 
The probability of HGT depends on the presence of bacteria with the capacity to develop genetic 
competence for transformation, i.e. to take up and recombine extracellular DNA. Several bacterial 
species with the potential to develop competence belong to the common gut microbial community 
(EFSA, 2009b; Rizzi et al., 2012). However, actual competence development and transformation of 
such bacteria by genomic DNA of plants has not yet been observed in the lower gastrointestinal tract 
even with optimised model systems providing a selective advantage (Nordgård et al., 2007; EFSA, 
2009b;  Rizzi  et  al.,  2012).  In  contrast,  some  studies  have  shown  that  introduced  bacteria  can  be 
naturally transformed in the oral cavity of humans and animals (Mercer et al., 1999a, b, 2001; Duggan 
et al., 2000, 2003). 
Risk characterisation 
Gastrointestinal bacteria of humans and animals and, in particular, of ruminants are expected to be 
exposed to the aadA–nptII–oriV DNA fragment from cotton MON 15985 by consumption of linters 
(consumed by humans and animals), cotton seeds and cottonseed meal (consumed by animals). Cotton 
seeds contain intact DNA, whereas cottonseed meal contains mainly fragmented DNA with a size 
smaller  than  that  of  the  above-mentioned  fragments
76.  DNA  is  substantially  degraded  in  the 
gastrointestinal  tract  of  animals  limiting  the  presence  of  gene -sized  DNA  fragments  in  this 
environment and in faeces (Jonas et al., 2001; Van den Eede et al., 2004). As cotton plant products are 
fed to animals in  only low amounts in the EU (FEDIOL, online;  Verstraete, 2013), the per animal 
exposure will be very low. 
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The  aadA  and  oriV  sequences  that  flank  the  nptII  gene  in  cotton  MON 15985  are  present  in 
naturallyoccurring bacteria in an arrangement which would allow double homologous recombination. 
The theoretical probability of horizontal transfer of the transgene sequences into bacteria is therefore 
higher compared to plant transgenes that do not have such flanking DNA sequences. The genetic 
composition of the inserted DNA in cotton MON 15985 facilitates homologous recombination with 
bacteria harbouring aadA and oriV sites in their DNA. Since such recombination sites are found 
located  on  mobile  genetic  elements,  rare  transfer  of  nptII  from  plant  material  to  bacteria  could 
theoretically be followed by higher frequency conjugative gene transfer to other bacteria and, thus, 
contribute to establishment of the nptII-encoded resistance trait in environmental bacterial populations. 
The  contribution  of  HGT  of  the  recombinant  nptII  gene  to  the  development  and  proliferation  of 
antibiotic-resistant bacteria should be seen in the context of the naturally ongoing resistance gene 
transfer  between  bacteria,  which  is  several  orders  of  magnitude  more  frequent  (Brigulla  and 
Wackernagel, 2010). The contribution of the frequency of HGT of the recombinant nptII gene must 
likewise  be  regarded  relative  to  the  natural  distribution  and  prevalence  of  nptII  genes  on  mobile 
genetic elements in bacteria. Bacteria carrying nptII on mobile genetic elements are found in various 
environments,  although  with  large  spatial  and  temporal  fluctuations  (EFSA,  2009b).  Moreover, 
resistance  genes  other  than  nptII  also  lead  to  the  distribution  and  prevalence  of  kanamycin-  and 
neomycin-resistant bacteria in various environments. 
There is limited information about the spatial and temporal variability in the selective conditions 
which would favour antibiotic-resistant bacteria, and in the occurrence, transferability and distribution 
of nptII genes in different environments. In addition, there is a lack of experimental data on HGT from 
cotton MON 15985. 
Conclusion 
The ERA indicates a negligible risk arising from a HGT of the aadA, uidA, cry1Ac and cry2Ab2 genes 
from cotton MON 15985 to bacteria because of the highly limited potential for transfer. However, for 
products from cotton MON 15985 containing transgenic DNA, there is an increased likelihood of 
stabilisation of the nptII gene from plant DNA in bacteria compared with plants not including sites for 
double homologous recombination. This increased likelihood of transfer must, however, be seen in the 
context of the gene transfer efficiencies between bacteria, which remains several orders of magnitude 
higher. 
Low-level  exposure  is  expected  for  bacteria  present  in  the  gastrointestinal  tracts  of  humans  and 
animals. Considering the low level of DNA exposure per animal and, hence, the low frequency of 
gene transfer from MON 15985 to bacteria compared with gene transfer frequencies between bacteria, 
the  GMO  Panel  concludes  that  MON 15985  material  is  highly  unlikely  to  contribute  to  the 
environmental prevalence of nptII genes. In summary, the analysis of HGT from cotton MON 15985 
to bacteria does not indicate a risk to human or animal health or to the environment in the context of 
its intended uses. 
(b) Plant to plant gene transfer 
Considering the intended uses of cotton MON 15985 and the physical characteristics of cotton seeds, a 
possible pathway of dispersal is from cottonseed spillage and pollen of occasional feral GM cotton 
plants originating from accidental cottonseed spillage during transportation and/or processing. 
The genus Gossypium consists of at least four species: G. arboreum, G. barbadense, G. herbaceum 
and G. hirsutum. G. herbaceum is reported (Zohary and Hopf, 2000) to be a traditional fibre crop in 
the Eastern Mediterranean area already in the pre-Columbus period (before 1500  AD). In Southern 
Europe,  G.  herbaceum  and  G.  hirsutum  have  been  grown  since  the  19
th  century,  giving  rise  to 
occasional feral plants in the same area (Davis, 1967; Tutin et al., 1992), but no sexually compatible 
wild relatives of G. hirsutum have been reported in Europe. Therefore, the plant to plant gene transfer 
from this GM cotton is restricted to cultivated and occasional feral populations. Scientific Opinion on genetically modified cotton MON 15985  
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Insect resistance to certain lepidopteran pests, such as CBW, PBW and TBW, provides an advantage 
in cultivation under infestation conditions. Survival of cotton outside cultivation in Europe is mainly 
limited by a combination of low competitiveness, absence of a dormancy phase, susceptibility to 
diseases and to cold climate conditions. Since these general characteristics of this GM cotton are 
unchanged, the inserted traits are not likely to provide a selective advantage outside cultivation in 
Europe (see Section 6.1.2.1). 
The  EFSA  GMO  Panel  also  takes  into  account  the  fact  that  this  application  does  not  include 
cultivation of the GM cotton MON 15985 within the EU so that the likelihood of cross-pollination 
between the imported GM cotton MON 15985 and cotton crops and occasional feral cotton plants is 
considered to be extremely low. Even if feral populations of cotton MON 15985 were established or 
transgene flow occurred to cultivated and feral cotton, a selective advantage would occur only under 
infestation of sensitive pest species. 
6.1.2.3.  Interactions of the GM plant with target organisms
77 
Owing to the  intended uses of cotton  MON 15985, which exclude cultivation, and the low level of 
exposure to the environment, potential interactions of the GM plant with target organisms were not 
considered an issue by the EFSA GMO Panel. 
6.1.2.4.  Interactions of the GM plant with non-target organisms
78 
Owing to the intended uses of cotton MON 15985, which excludes cultivation, and because of the low 
level of exposure to the environment, potential interactions of the GM cotton with non -target 
organisms (NTOs) were not considered an issue by the EFSA GMO Panel. 
However, the EFSA GMO Panel evaluated whether the Cry proteins might potentially affect NTOs by 
entering the environment through faecal material from animals fed with this GM cotton. Owing to the 
specific insecticidal selectivity of Cry proteins, NTOs most likely to be affected b y the Cry2Ab2 and 
Cry1Ac proteins belong to  the  same or closely related taxonomic group as those of the target 
organisms. 
Data supplied by the applicant suggest that only low amount s of the Cry2Ab2 and Cry1Ac proteins 
enter the environment  owing to low  expression in cotton seeds (2.21 –4.84 and 31.8–50.7 µg/g dry 
weight). Moreover, these Cry proteins are degraded by enzymatic activity in the gastrointestinal tract 
of animals fed on cotton MON 15985 or derived products (see Section 5.1.4.2), meaning that only low 
amounts of Cry proteins would remain intact to pass into faeces. This was demonstrated for Cry1Ab 
(Einspanier et al., 2004; Lutz et al., 2005, 2006; Wiedemann et al., 2006; Guertler et al., 2008). There 
would subsequently be further degradation of these Cry proteins in the faecal material due to intrinsic 
microbial proteolytic activity. In addition, there will be further degradation of Cry proteins in soil, 
reducing the possibility for the exposure of potentially sensitive NTOs. While Cry proteins may bind 
to clay minerals and humic substances in soil, thereby reducing their availability to microorganisms 
for degradation, there are no indications of persistence and accumulation of Cry proteins from GM 
crops in soil (reviewed by Icoz and Stotzky, 2008). The EFSA GMO Panel is not aware of evidence of 
released  Cry  proteins  from  GM  plants  causing  significant  negative  effects  on  soil  micro-  or 
macroorganisms. Considering the scope of the application, it can be concluded that the exposure of 
potentially sensitive NTOs to the Cry2Ab2 and Cry1Ac proteins is likely to be very low and of no 
biological relevance. 
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6.1.2.5.  Potential interactions with the abiotic environment and biochemical cycles
79 
Given the scope of this application, which excludes cultivation of  cotton MON 15985, and the low 
level  of  exposure  to  the  environment,  potential  interactions  with  the  abiotic  environment  and 
biogeochemical cycles are not considered to be a relevant issue by the EFSA GMO Panel. 
6.1.3.  Post-market environmental monitoring
80 
The objectives of a monitoring plan, according to Annex VII of Directive 2001/18/EC, are (1) to 
confirm that any assumption regarding the occurrence and impact of potential adverse effects of the 
GMO, or its use, in the ERA are correct and (2) to identify the occurrence of adverse effects of the 
GMO, or its use, on human health or the environment which were not anticipated in the ERA. 
Monitoring is related to risk management and, thus, a final adoption of the PMEM plan falls outside 
the mandate of EFSA. However, the EFSA GMO Panel gives its opinion on the scientific content of 
the  PMEM  provided  by  the  applicant  (EFSA,  2006d;  EFSA  GMO  Panel,  2011d).  The  potential 
exposure to the environment, including humans and animals, of cotton MON 15985 would be mainly 
ingestion by animals and their faecal material leading to exposure of gastrointestinal tract and soil 
microorganisms, and with the accidental release into the environment of viable cotton MON 15985 
seeds during transport and/or processing. 
The scope of the PMEM provided by the applicant is in line with the intended uses. As the ERA did 
not  identify  potential  adverse  environmental  effects  due  to  cotton  MON 15985,  no  case-specific 
monitoring is required. 
The PMEM plan proposed by the applicant includes (1) the description of an approach involving 
operators  (federations  involved  in  cotton  import  and  processing)  reporting  to  the  applicant  via  a 
centralised system any observed adverse effect(s) of GMOs on human health and the environment; (2) 
a coordinating system established by EuropaBio for the collection of the information recorded by the 
various operators; and (3) the use of networks of existing surveillance systems (Lecoq et al., 2007; 
Windels et al., 2008). The applicant proposes to submit a PMEM report on an annual basis and a final 
report at the end of the consent. 
The EFSA GMO Panel is of the opinion that the scope of the PMEM proposed by the applicant is in 
line with the intended uses of cotton MON 15985 as the ERA did not cover cultivation and identified 
no potential adverse environmental effects. The EFSA GMO Panel agrees with the reporting intervals 
proposed by the applicant in its PMEM plan. 
The EFSA GMO Panel advises that appropriate management systems should be in place to restrict 
seeds  of  cotton  MON 15985  entering  cultivation  as  the  latter  requires  specific  approval  under 
Directive 2001/18/EC or Regulation (EC) No 1829/2003. 
6.2.  Conclusion 
The  scope  of  applications  EFSA-GMO-UK-2008-57  and  EFSA-RX-MON15985  covers  cotton 
MON 15985 for food and feed uses, import and processing, food additives produced from cotton 
MON 15985, feed produced from cotton MON 15985 (feed materials and feed additives) and does not 
include cultivation. Considering the intended uses of cotton MON 15985, the ERA is concerned with 
the exposure mainly through ingestion by animals and their faecal material leading to exposure of 
gastrointestinal tract and soil microorganisms, and with the accidental release into the environment of 
viable seeds of cotton MON 15985 during transport and processing. 
In the case of accidental release into the environment of viable seeds of cotton MON 15985, there are 
no indications of an increased likelihood of establishment and spread of feral cotton  MON 15985 
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plants, except under conditions of infestation of specific target pests. The low levels of environmental 
exposure of these GM cotton plants indicate that the risk to NTOs is extremely low. 
No risk arising from the HGT of the aadA, cry1Ac, cry2Ab2 and uidA genes from cotton MON 15985 
to bacteria has been identified. An increased likelihood of stabilisation of the nptII gene from cotton 
MON 15985 DNA in bacteria was postulated. However, considering the expected low frequency of 
gene transfer from plants to bacteria compared with that between bacteria, and the low exposure to 
MON 15985  DNA,  the  GMO  Panel  concludes  that  it  is  highly  unlikely  that  MON 15985  will 
contribute  to  the  environmental  prevalence  of  nptII  genes.  The  analysis  of  HGT  from  cotton 
MON 15985 to bacteria does not indicate a risk to human or animal health or to the environment in the 
context of its intended uses. 
The scope of the PMEM plan provided by the applicant and the reporting intervals are in line with the 
intended uses of cotton MON 15985 and the guidance document of the EFSA GMO Panel on PMEM 
of  GM  plants  (EFSA,  2006d;  EFSA  GMO  Panel,  2011d).  In  addition,  the  EFSA  GMO  Panel 
acknowledges the approach proposed by the applicant to put in place appropriate management systems 
to restrict environmental exposure due to possible cases of accidental release of viable seeds of cotton 
MON 15985. The EFSA GMO Panel agrees with the reporting intervals proposed by the applicant in 
the PMEM plan. 
OVERALL CONCLUSIONS AND RECOMMENDATIONS 
The EFSA GMO Panel was asked to carry out a scientific assessment of cotton MON 15985 for food 
and feed uses, import and processing in accordance with Regulation (EC) No 1829/2003. 
The molecular characterisation data provided for cotton MON 15985 did not give rise to safety issues. 
The  EFSA  GMO  Panel  could  not  complete  the  assessment  of  the  agronomic  and  phenotypic 
characteristics of cotton MON 15985 on the basis of the data provided, derived from a single season 
and fewer than eight sites (EFSA, 2006a; EFSA GMO Panel 2011a). Therefore, the EFSA GMO Panel 
could not conclude on the potential occurrence of unintended effects based on the outcome of the 
agronomic and phenotypic analysis. The EFSA GMO Panel concludes that the compositional data give 
no indication that the genetic modification induces unintended effects for which further assessment is 
needed. The EFSA GMO Panel concludes that cotton MON 15985 is as safe and nutritious as its 
conventional counterpart and that it is unlikely that the overall allergenicity of the whole plant is 
changed. 
Considering the intended uses of cotton MON 15985, the environmental risk assessment is concerned 
with  the  exposure  through  faecal  material  from  animals  fed  with  cotton  products  from  cotton 
MON 15985  and  with  the  accidental  release  into  the  environment  of  viable  grains  of  cotton 
MON 15985 during transport and processing. Notwithstanding the incompleteness of the agronomic 
and  phenotypic  dataset,  the  EFSA  GMO  Panel  followed  a  weight  of  evidence  approach  and, 
considering the scope of this application and the poor ability of cotton to survive outside cultivated 
fields, concluded that there is very low likelihood of any adverse environmental impacts due to the 
accidental release into the environment of viable seeds from cotton MON 15985. No risk arising from 
a HGT of the aadA, cry1Ac, cry2Ab2 and uidA genes from cotton MON 15985 to bacteria has been 
identified. An increased likelihood of stabilisation of the nptII gene from cotton MON 15985 DNA in 
bacteria  was  postulated.  However,  considering  the  expected  low  frequency  of  gene  transfer  from 
plants to bacteria compared with that between bacteria, and the low exposure to MON 15985 DNA, 
the  GMO  Panel  concludes  that  it  is  highly  unlikely  that  MON 15985  will  contribute  to  the 
environmental prevalence of nptII genes. The analysis of HGT from cotton MON 15985 to bacteria 
does not indicate a risk to human or animal health or to the environment in the context of its intended 
uses. Scientific Opinion on genetically modified cotton MON 15985  
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The scope of the PMEM plan provided by the applicant and the reporting intervals are in line with the 
intended uses of cotton MON 15985 and the guidance document of the EFSA GMO Panel on PMEM 
of  GM  plants  (EFSA  2006d;  EFSA  GMO  Panel  2011d).  In  addition,  the  EFSA  GMO  Panel 
acknowledges the approach proposed by the applicant to put in place appropriate management systems 
to restrict environmental exposure in cases of accidental release of viable seeds of cotton MON 15985. 
The EFSA GMO Panel agrees with the reporting intervals proposed by the applicant in the PMEM 
plan. 
The EFSA GMO Panel considers that the dossiers presented by the applicant had deficiency in the 
data set relative to agronomic and phenotypic trials, however the EFSA GMO Panel concludes that 
cotton  MON 15985,  as  described  in  applications  EFSA-GMO-UK-2008-57  and  EFSA-GMO-RX-
MON15985, is as safe as its conventional counterpart and non-GM cotton commercial varieties and is 
unlikely to have adverse effects on human and animal health and the environment in the context of the 
scope of these applications. Scientific Opinion on genetically modified cotton MON 15985  
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DOCUMENTATION PROVIDED TO EFSA IN RELATION TO EFSA-GMO-UK-2008-57 
1.  Letter  from  the  Competent  Authority  of  the  United  Kingdom,  received  22  May  2008, 
concerning  a  request  for  placing  on  the  market  of  cotton  MON 15985   MON  1445  in 
accordance with Regulation (EC) No 1829/2003. 
2.  Acknowledgement letter, dated 5 June 2008, from EFSA to the Competent Authority of the 
United Kingdom. 
3.  Letter from EFSA to applicant, dated 17 July 2008, requesting additional information under 
completeness check 
4.  Letter from applicant to EFSA, received 24 July 2008, providing additional information under 
completeness check. 
5.  Letter from EFSA to applicant, dated 20 August 2008, delivering the ‗Statement of Validity‘ of 
application  EFSA-GMO-UK-2008-57  (cotton  MON 15985   MON  1445)  submitted  by 
Monsanto under Regulation (EC) No 1829/2003. 
6.  Letter from EFSA to applicant, dated 20 August 2008, requesting additional information and 
stopping the clock. 
7.  Letter from applicant to EFSA, received 2 September 2008, providing additional information. 
8.  Letter from EFSA to applicant, dated 24 November 2008, requesting additional information and 
maintaining the clock stopped. 
9.  Letter  from  EFSA  to  applicant,  dated  7  April  2009,  requesting  additional  information  and 
maintaining the clock stopped. 
10.  Letter  from  EFSA  to  applicant,  dated  28  May  2009,  requesting  additional  information  and 
maintaining the clock stopped. 
11.  Letter from EFSA to applicant, dated 18 September 2009, requesting additional information and 
maintaining the clock stopped. 
12.  Letter from EFSA to applicant, dated 15 March 2010, requesting additional information and 
maintaining the clock stopped. 
13.  Letter from applicant to EFSA, received 8 June 2010, providing additional information. 
14.  Letter from EFSA to applicant, dated 3 August 2010, requesting clarifications. 
15.  Letter  from  applicant  to  EFSA,  received  15  September  2010,  providing  the  clarifications 
requested. 
16.  Letter from EFSA to applicant, dated 4 October 2010, requesting additional information and 
maintaining the clock stopped. 
17.  Letter from applicant to EFSA, received 2 December 2010, providing additional information. 
18.  Letter from EFSA to applicant, dated 31 January 2011, requesting additional information and 
maintaining the clock stopped. 
19.  Letter from applicant to EFSA, received 11 April 2011, providing additional information. Scientific Opinion on genetically modified cotton MON 15985  
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20.  Letter from EFSA to applicant, dated 21 September 2011, re-starting the clock. 
21.  Letter from EFSA to applicant, dated 5 December 2011, requesting additional information and 
stopping the clock. 
22.  Letter  from  EFSA  to  applicant,  dated  6  July  2012,  requesting  additional  information  and 
maintaining the clock stopped. 
23.  Letter from EFSA to applicant, dated 12 July 2012, requesting clarifications on the progress of 
the application. 
24.  Letter from applicant to EFSA, received on 20 August 2012, providing clarifications on the 
progress of the applications. 
25.  Letter from applicant to EFSA, received 15 September 2012, providing clarifications on the 
progress of the application. 
26.  Letter from applicant to EFSA, received 14 September 2012, providing additional information. 
27.  Letter from EFSA to applicant, dated 9 October 2012, regarding the progress of the application. 
28.  Letter from applicant to EFSA, received 5 November 2012, providing additional information. 
29.  Letter from EFSA to applicant, dated 9 January 2013, requesting additional information and 
maintaining the clock stopped. 
30.  Letter from applicant to EFSA, received 12 March 2013, requesting clarifications on the EFSA 
letter dated 9 January 2013. 
31.  Letter  from  EFSA  to  applicant,  dated  3  June  2013,  requesting  additional  information  and 
maintaining the clock stopped. 
32.  Letter from EFSA to applicant, dated 23 August 2013, requesting additional information and 
maintaining the clock stopped. 
33.  Letter from applicant to EFSA, received 5 November 2013, providing additional information. 
34.  Letter from applicant to EFSA, received 11 November 2013, providing additional information. 
35.  Letter from EFSA to applicant, dated 29 April 2014, re-starting the clock. 
DOCUMENTATION PROVIDED TO EFSA IN RELATION TO EFSA-GMO-RX-MON15985 
1.  Letter from the European Commission, received 28 June 2007, concerning a request for renewal 
of the authorisation for the placing on the market of cotton MON 15985 in accordance with 
Regulation (EC) No 1829/2003. 
2.  Acknowledgement letter, dated 20 July 2007, from EFSA to the European Commission. 
3.  Letter  from  EFSA  to  applicant,  dated  3  December  2007,  requesting  additional  information 
under completeness check. 
4.  Letter from applicant to EFSA received 26 February 2008 providing additional information 
under completeness check. Scientific Opinion on genetically modified cotton MON 15985  
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5.  Letter from EFSA to applicant, dated 18 March 2008, delivering the ‗Statement of Validity‘ for 
application EFSA-GMO-RX-MON15985 (cotton MON 15985 ) submitted by Monsanto under 
Regulation (EC) No 1829/2003. 
6.  Letter  from  EFSA  to  applicant,  dated  26  May  2008,  requesting  additional  information  and 
stopping the clock. 
7.  Letter from applicant to EFSA, received 28 October 2008, providing additional information. 
8.  Letter from EFSA to applicant, dated 24 November 2008, requesting additional information and 
maintaining the clock stopped. 
9.  Letter from applicant to EFSA, received 9 March 2009, providing additional information. 
10.  Letter  from  EFSA  to  applicant,  dated  7  April  2009,  requesting  additional  information  and 
maintaining the clock stopped. 
11.  Letter from applicant to EFSA, received 18 May 2009, providing additional information. 
12.  Letter  from  EFSA  to  applicant,  dated  26  May  2009,  requesting  additional  information  and 
maintaining the clock stopped. 
13.  Letter from EFSA to applicant, dated 18 September 2009, requesting additional information and 
maintaining the clock stopped. 
14.  Letter from applicant to EFSA, received 18 January 2010, providing additional information. 
15.  Letter from EFSA to applicant, dated 12 March 2010, requesting additional information and 
maintaining the clock stopped. 
16.  Letter from EFSA to applicant, dated 2 August 2010, requesting clarifications. 
17.  Letter  from  applicant  to  EFSA,  received  15  September  2008,  providing  the  clarifications 
requested. 
18.  Letter from applicant to EFSA, received 29 September 2008, providing clarifications. 
19.  Letter from EFSA to applicant, dated 4 October 2010, requesting additional information and 
maintaining the clock stopped. 
20.  Letter from applicant to EFSA, received 2 December 2010, providing additional information. 
21.  Letter from EFSA to applicant, dated 31 January 2011, requesting additional information and 
maintaining the clock stopped. 
22.  Letter from applicant to EFSA, received 11 April 2011, providing additional information. 
23.  Letter from EFSA to applicant, dated 21 September 2011, re-starting the clock. 
24.  Letter from EFSA to applicant, dated 5 December 2011, requesting additional information and 
stopping the clock. 
25.  Letter  from  EFSA  to  applicant,  dated  6  July  2012,  requesting  additional  information  and 
maintaining the clock stopped. Scientific Opinion on genetically modified cotton MON 15985  
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26.  Letter from EFSA to applicant, dated 12 July 2012, requesting clarifications on the progress of 
the application. 
27.  Letter from applicant to EFSA, received on 20 August 2012, providing clarifications on the 
progress of the applications. 
28.  Letter from applicant to EFSA, received 14 September 2012, providing additional information. 
29.  Letter from EFSA to applicant, dated 9 October 2012, regarding the progress of the application. 
30.  Letter from applicant to EFSA, received 5 November 2013, providing additional information. 
31.  Letter from EFSA to applicant, dated 9 January 2013, requesting additional information and 
maintaining the clock stopped. 
32.  Letter from applicant to EFSA, received 12 March 2013, requesting clarifications on the EFSA 
letter dated 9 January 2013. 
33.  Letter  from  EFSA  to  applicant,  dated  3  June  2013,  requesting  additional  information  and 
maintaining the clock stopped. 
34.  Letter from EFSA to applicant, dated 23 August 2013, requesting additional information and 
maintaining the clock stopped. 
35.  Letter from applicant to EFSA, received 5 November 2013, providing additional information. 
36.  Letter from applicant to EFSA, received 11 November 2013, providing additional information. 
37.  Letter from EFSA to applicant, dated 29 April 2014, re-starting the clock. Scientific Opinion on genetically modified cotton MON 15985  
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